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INTRODUCTION 
Herbal medicine is one of the oldest and most universal system of health care system. The 
advancement in the field of herbal drug delivery started recently with the aim to manage human 
diseases efficiently. World Health Organization (WHO) estimates that 80% of the world 
populations presently use herbal medicine for primary health care. Every nation is seeking health 
care beyond the traditional boundaries of modern medicine; turning to self medication in the 
form of herbal remedies. 1 Modern herbal medicine is based upon the combination of traditional 
knowledge, clinical experience, understanding of medicinal science and scientific evidence of 
herbal medicine. People are slowly and gradually switching to alternative forms of medicine. 
One of these many alternative therapies include herbal system of medicine. It is made of from an 
extract taken from the plant parts (leaf, root, flower and bark). They are absolutely natural and 
safe form of curing illness form occurring repeatedly. They help in curing the ailment and are 
also known to prevent the illness from occurring   repeatedly. Herbal medicines may have long 
curing periods, but they eradicate the illness from it and prevent any future episodes of the 
same.2  
Despite criticism of  herbal medicine among mainstream medical professionals , it is wise to 
remember that many common drugs we use today were derived from plant based sources .Many 
of the pharmaceuticals currently available to physicians have a long history of use as herbal 
remedies , including opium , aspirin , digitalis and quinine  . According to World Health 
Organization (WHO) approximately 25% of modern drugs used have been derived from plants. 
At least 7000 medical compounds in modern pharmacopoeia are  derived from plants .Among  
the active compounds currently isolated from the higher plants and which are widely used in 
modern medicine today show a positive correlation between their modern therapeutic use and the 
traditional use of  the plants from which they are derived.3 
Advantages of herbal system of medicines4: 
 Lower risk of side effects  
 Widespread availability  
 Effectives with chronic medicine 
 Low cost effectiveness make them all the more alluring  
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 Efficacious for life style diseases for prolonged period of time  
 Natural detoxification process of the body is effectively enhanced by herbal medicine. 
 These type of formulation are best for the people who are allergic to various types of 
drugs. 
 These types of medicines do not have any types of side effects as they are free from 
chemicals.   
Disadvantages of herbal system of medicines5: 
 Bulk dosing. 
 Poor stability in higher acidic pH, liver metabolism etc.  
 Large molecular size limiting the absorption via passive diffusion. 
 Poor lipid solubility hence preventing their ability to cross the lipid-rich biological 
membranes. 
 High mount of raw material is required for processing the medicine. 
 Isolation and purification of individual components from whole herbal extract lead to 
partial or total loss of therapeutic activity 
These limitation lead to reduced bioavailability and hence, low therapeutic index of plant active 
constituents. Often, the natural synergy is gone which is due to chemically related constituents 
present in herbal extract. Hence considerable attention has been given to development of novel 
drug delivery system for herbal drugs.  
Novel Herbal Drug Delivery System6 
Novel herbal drug delivery system opens new way for delivery of herbal drugs at right place, at 
right concentration, for right period of time and also gives scientific evidence to verify the 
standardization of herbal drug. With the progress in all fields of science and technology, the 
dosage forms have evolved from simple pills to highly sophisticated technology intensive drug 
delivery systems, which are known as Novel Drug Delivery System (NDDS). In the past decades 
considerable attention has been focused on the development of novel drug delivery systems for 
herbal drugs. Herbal drugs are becoming more popular in the modern world for their ability to 
cure various diseases with less toxic effects and better therapeutic effects. 
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Importance of novel herbal drug delivery system7 
Most of the active constituents present in the herbal drugs are  flavonoids, glycosides etc. These 
are mainly hydrophilic molecules due to that they are  limited in their effectiveness and are 
poorly absorbed when they are taken internally and when applied topically. Apart from that due 
to its larger molecular size which cannot be absorbed by passive diffusion and due to their poor 
lipid solubility limiting its ability to pass across the lipid-rich outer membranes of the enterocytes 
(the cells that line the small intestine) resulting poor bioavailability of drugs. Therefore, a larger 
dose is usually required for dosage regimens. These aspects constitute a drawback against the 
widespread usage of phyto medicines in the pharmaceutical field. The effectiveness of many 
herbal drugs is mainly based upon delivering an effective level of the active phyto constituents 
present in it. These can be overcome by suitable incorporation of the novel drug delivery 
technology to herbal extracts minimizes the drug degradation or pre systemic metabolism and 
serious side effects by accumulation of drugs to the non targeted areas and improves the ease of 
administration in patients. 
 Various phytochemical and phyto pharmacological studies proves that the compositions, 
therapeutics and overall health enchancing capacities of various plant extracts but there is a great 
interest and medical need for the improvement of bioavailability of   large number of herbal 
drugs and plant extracts which  is having poor lipid solubility and poor bioavailability7. 
 Many herbal drugs unlike their extraordinary  potential in-vitro finding shows less or no in-vivo 
actions as a reason of its poor lipid solubility and larger molecular size finally resulting poor 
absorption and bioavailability of the drug.5 Numerous phytoconstituents present in it may 
produce a combined action of the phytoconstituents and  various methods like purification and 
separation of the plant parts leads to a partial loss of specific activity due to the removal of 
chemically related substances contributing the activity of the main components present in it. 
Very often the chemical complexity of the extract is important for the bioavailability of the 
active components. Most of the plant constituents specifically phenolics are water soluble and so 
the major problem for less bioavailability is the inability to cross the lipid rich biological 
membranes.8 
 Novel drug delivery system is useful in delivering the herbal drug at a predetermined rate and 
delivery of drug at the site of action which reduces the side effects with increase in 
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bioavailability of drugs. In novel drug delivery technology control of the distribution of drugs is 
obtained by incorporating the drug in suitable carrier system or by converting the structure of the 
drug at molecular level. Incorporation of herbal drugs in the delivery system also aids to increase 
its solubility, enhanced stability, protection from toxicity, enhanced pharmacological activity, 
improved tissue macrophage distribution , sustained delivery and protection from physical and 
chemical degradation .For good bioavailability natural products must have a good balance 
between hydrophilicity and lipophilicity to cross lipid biological membranes.5  
The novel carrier should ideally fulfill to requirements such as it should deliver the drug at the 
rate directed by the needs of the body and over the period of treatment secondly it should be a 
channel for the active entry of herbal drug to the site of action. Incorporating the herbal drugs 
into the novel drug delivery system reduces the repeated administration of drug to overcome 
non-compliance which helps to increase the therapeutic value by reducing toxicity and increases 
the bioavailability. Novel drug delivery admits to either prolonged drug action at a 
predetermined rate or by maintaining the relatively constant active drug level in the body with 
minimization of undesirable toxic effects.1 
Advantages of Novel herbal drug delivery system5 
 Help to increase the efficacy and reduce the side effect of various herbal compounds. 
 Quantity of component becomes less with improving quality of drug effect. 
 Fewer raw material are required to achieve the desire effect and control drug delivery to 
provide exact specification regarding drug dose form. 
 Ready to use devices are acceptable in today's fast life style where time is important. 
 Carry maximum amount of drug to the site of action by passing all barriers such as acidic 
pH of stomach  
 Increases prolong circulation of drug into blood due to their small particle size. 
 Reduce repeat dose administration. 
            Recent adavances in Novel Herbal Drug Delivery Systems5-11 
Various approaches  in case of novel herbal drug delivery includes different types of 
formulations such as liposomes , phytosomes , niosomes , nanoparticles , microspheres , 
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transferosomes , ethosomes , herbal transdermal patches and proniosome etc. are discussed as 
follows : 
(A) Liposomes 
The liposomes are spherical particles that encapsulate a fraction of the solvent, in which they 
freely diffuse (float) into their interior. They can have one, several or multiple concentric 
membranes. Liposomes are constructed of polar lipids which are characterized by having a 
lipophilic and hydrophilic group on the same molecule. Upon interaction with water, polar lipids 
self assemble and form self organized colloidal particles .Liposome depict the hydrophilic heads 
of the amphiphile orienting towards the water compartment while the lipophilic tails orient away 
from the water towards the center of the vesicle, thus forming a bilayer . Consequently water 
soluble compounds are entrapped in the water compartment and lipid soluble compounds 
aggregate in the lipid section .Thus liposomes can encapsulate both hydrophilic and lipophilic 
materials.  They are usually formed from phospholipids, have been used to change the 
pharmacokinetic profile of not only drugs but herbs vitamins and enzymes. 
 (B) Niosomes 
Niosomes are microscopic lamellar structures formed on admixture of a nonionic surfactant, 
cholesterol and a charge inducing agent with subsequent hydration in aqueous media. Niosomes 
possess an infrastructure consisting of hydrophobic and hydrophilic moieties together and as a 
result can accommodate drug molecules with a wide range of solubility‟s. Niosomes have been 
evaluated in many pharmaceutical applications. In such therapeutic applications, important 
advantages of using niosomes include their ability to reduce systemic toxicity by encapsulation 
of treatment agents and minimize clearance of such agents from the body by slow drug release. 
(C) Nanoparticles 
Nanoparticles are defined as particulate dispersions or solid particles with a size in the range of 
10-1000nm. The drug is dissolved, entrapped, encapsulated or attached to a nanoparticle matrix. 
The major goals in designing nano particles as a delivery system are to control particle size, 
surface properties and release of pharmacologically active agents in order to achieve the site-
specific action of the drug at the therapeutically optimal rate and dose regimen. Nanoparticles 
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offer some specific advantages such as they help to increase the stability of drugs/proteins and 
possess useful controlled release properties. It can be modified to achieve both active and passive 
targeting; drug loading is very high and can be administered by various routes such as parenteral, 
nasal, intra ocular and oral routes. 
(D) Microspheres 
Microspheres are solid, almost spherical in nature, having a diameter in the range of 1 um to 
1000um. Microspheres are having wide commercial applications including sustained drug 
delivery, overcome handling issues with potent molecules and improved targeting at the active 
site in desired concentration to maintain overall effective plasma concentration for a longer 
period of time. Microspheres are widely used as drug delivery carrier for targeting of various 
agents that cause dose-dependent adverse effects. In recent times, microspheres are widely used 
to enhance the therapeutic potential of various poorly soluble phytoconstituets. 
(E) Transferosomes 
Transfersome carrier is an artificial vesicle which resembles the natural cell vesicle. Thus it is 
suitable for targeted and controlled drug delivery. Transfersome is a highly adaptable and stress-
responsive, complex aggregate. It is an ultra-deformable vesicle which possesses an aqueous 
core surrounded by the complex lipid bilayer. Interdependency of local composition and shape of 
the bilayer makes the vesicle both self-regulating and self-optimising. This enables the 
Transfersome to cross various transport barriers efficiently, and then act as a drug carrier for 
non-invasive targeted drug delivery and sustained release of therapeutic agents. These self-
optimized aggregates, with the ultra-flexible membrane, are able to deliver the drug reproducibly 
either into or through the skin, depending on the choice of administration or application, with 
high efficiency. 
(F)Ethosomes 
Ethosomes are developed by mixture of phospholipids and high concentration of ethanol. This 
carrier can penetrate through the skin deeply lead to improve drug delivery into deeper layer of 
skin and in blood circulation. They may form multilamellar vesicles and have a high entrapment 
capacity for molecules of various lipophilicities.  They are mainly used as drug carriers for a 
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range of small molecules,various phytoconstituents , peptides, proteins and vaccines .  They 
show increase in their permeability through the skin by fluidizing the lipid domain of the skin. 
(F)Herbal transdermal patches 
Transdermal drug delivery systems facilitate the passage of therapeutic quantities of drug 
substances through the skin and into the general circulation for their systemic effects. Herbal 
transdermal patches are medicated adhesive pad designed to release active ingredients at a 
constant rate over a period of several hours or days after application to skin. Herbal penetration 
enhancers like some terpenes are found to be potential enough to replace the conventionally 
available penetration enhancers. 
(G) Phytosomes 12,16 
The phytosome are newly introduced structures, which contain the active ingredients of herb 
surrounded and bound by phospholipids. These are the newly introduced patented technology 
developed to incorporate standardized plant extracts or water soluble phytoconstituents into 
phospholipids to produce lipid compatible molecular complexes, called as phytosomes.  It results 
from reaction of stoichiometric amount of phospholipid mostly phosphatidylcholine with a 
standardized herbal extract in an aprotic solvent. It mainly contains the bioactive 
phytoconstituents of herb surrounds and bound by a lipid. 
                                            
                                              Figure no : 1 The phytosome complex 
 
Most of phytoconstituents of herbal extracts are water soluble and poorly miscible with oils and 
other lipids. Lipid solubility and molecular size of phytoconstituents are the major limiting 
factors for molecule to pass the biological membrane to be absorbed systemically following the 
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oral or topical administration. The bioavailability of phytoconstituents can be increased by use of 
novel drug delivery system, which can increase the phytoconstituents solubility in 
gastrointestinal fluid as well as capacity to cross lipid rich biological membrane.6  Phytosome of 
herbal extract is generally more bioavailable than a simple herbal extract due to its enhanced 
capacity to cross the lipid-rich biomembranes. Phytosome technology is a breakthrough model 
for marked enhancement of bioavailability, significantly greater clinical benefit, assured delivery 
to the tissues, and without compromising nutrient safety.  They have improved pharmacokinetic 
and pharmacological parameters which are advantageous in the treatment of acute diseases as 
well as in pharmaceutical and cosmetic compositions.13 
 
Phosphatidylcholine: as carrier for herbal drugs20,22 
Phosphatidylcholine is the principal molecular building block of cell membranes miscible both in 
water and in oil environments, and is well absorbed when taken by orally or  topically . They are 
a major component of biological membrane and can be isolated from either egg yolk or soy 
beans from which it is mechanically or chemically extracted using hexane. The choline head of 
the phosphatidylcholine molecule binds to these compounds while the fat‐soluble phosphatidyl 
portion comprising the body and tail then envelopes the choline‐bound material. As a result a 
little microsphere or cell like structure will appear. 
The phytosome technology creates intermolecular bonding between individual polyphenol 
molecules and one or more molecules of the phosphatidylcholine or phospholipids. A bond is 
formed between these two molecules, creating a hybrid molecule. This highly lipid‐miscible 
hybrid bond is better suited to merge into the lipid phase of the enterocyte's outer cell membrane 
so they are more bioavailable as compared with conventional herbal extracts owing to their 
enhanced capacity to cross the lipid-rich biomembranes and, finally, reach the blood.15 
. 
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                     Figure no: 2  Structure of phosphatidylcholine 
 
            Advantages Of Phytosomes 12,16 
1. Potential enhancement of bioavailability.  
2. Herbal phytosome process produces a little cell whereby the valuable components of the 
herbal extracts are protected from destruction by digestive secretions and gut bacteria.  
3. Pharmacologically Assured delivery to the different biological tissues.  
4. No compromise of nutrient safety.  
5. Less dose requirement is due to absorption of chief constituent.  
6. Drug loading efficiency is so high and more over predetermined because drug itself in 
conjugation with lipids is forming vesicles.  
7. No problem of drug entrapment.  
8. Phytosomes shows better stability profile because chemical bonds are formed between  
phosphatidylcholine molecules and phytoconstituents.  
9. Phosphatidylcholine used in the phytosome process which acting as a carrier and also 
nourishes the skin, because it is essential part of cell membrane.  
10. Phytosome is also superior to liposomes in skin care products.  
11. Significantly gives greater clinical benefit than liposomes.  
12. The structure of phytosome elicits peculiar properties and advantages in cosmetic 
application.  
                                                                                                                                       Introduction 
 
Dept of Pharmaceutics, KMCH College of Pharmacy Page 10 
 
13. Significantly enhanced ability of phyosome to cross cell membranes and enter cells.  
14. Their low solubility in aqueous media allows the formation of stable emulsions or creams 
15. Relatively simple to manufacture with no complicated technical investment required for the 
production of phytosomes. 
 
            Properties of phytosomes 16,17,19 
1. Chemical properties  
Phytosomal complex is obtained by reaction of stoichiometric amounts of phospholipid and the 
substrate in an appropriate solvent. On the basis of spectroscopic data it has been shown that the 
main phospholipid-substrate interaction is due to the formation of hydrogen bonds between the 
polar head of phospholipids (i.e. phosphate and ammonium groups) and the polar functionalities 
of the substrate. in phytosomes the active principle is anchored to the polar head of 
phospholipids, becoming an integral part of the membrane This can be deduced from the 
comparison of the NMR of the complex with those of the pure precursors. The signals of the 
fatty chain are almost unchanged. Such evidences inferred that the two long aliphatics chains are 
wrapped around the active principle, producing a lipophilic envelope, which shields the polar 
head of the phospholipid and the phytoconstituent. 
2. Biological Properties  
Phytosome are advanced forms of herbal products that are better absorbed, utilized and as a 
result produce better results than conventional herbal extracts the increased bioavailability of the 
phytosome over the non complexed botanical derivatives has been demonstrated by 
pharmacokinetics studies or by pharmacodynamic tests in experimental animals and in human 
subjects.  
3. Pharmacological properties 
 Phytosomes are advanced form of herbal products that are better absoebed, utilised and as a 
result produce better results than conventional herbal extracts. The increased bioavailability of 
phytosomes over noncomplexed botanical derivatives has been demonstrated by 
pharmacokinetic studies or by pharmacodyanamic tests in experimental amials and human 
subjects. 
 
PHYTOSOMES: A Novel approach towards topical drug delivery system 18 
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The skin is the biggest organ of the human body and provides a protective barrier 
against various harmful microbes, chemicals and ultraviolet radiation. Natural plant 
products have been formulated to heal and prevent dry skin, treat skin conditions 
such as eczema and acne and retard the aging process. As we grow older, the process 
of cell replication and many other complex cellular pathways breaks down and the 
body begins to make mistakes. In the same way that our reactions slow down as we age, 
so too our cells make errors and function more slowly. Young vibrant elastic collagen 
becomes progressively sluggish and inelastic, skin becomes more lined and wrinkled, 
colour and freshness are slowly replaced with dull, lifeless skin often speckled with 
discoloured patches where the deposition of melanin has become uneven and erratic.  
Plant flavonoids have local action on some diseases like inflammation, oedema, pain, 
fungal infections etc. But their use in topical application is restricted due to poor 
absorption through skin. Phytosomes improve absorption of phytoconstituents 
through skin, to regulate the physiology of skin compositions. The improvement in the 
functioning of skin suggests the functional importance of the phytosomes.8 Generally 
the passage of the compounds anchored to phospholipids takes place through 
interaction with cutaneous structure, which influences the release of the 
phytoconstituents. The rate of absorption from the complex is dramatically enhanced 
without damaging the epidermis, which suggesting potential use of phytoconstituent- 
phospholipids complex for cosmetic value in skin as well as for systemic function via 
skin. Therefore application of natural molecules in form of phytosome improves its 
absorption, nourishes the skin and act as a topical drug delivery system. 
           Skin Structure and Skin Alterations Due to Aging18 
Structure of skin is shown figure no: 3. The aging of human skin is primarily caused by 
exposure to the ultraviolet radiation of the sun. There are two main process of skin aging: 
intrinsic and extrinsic. Intrinsic aging reflects the genetic background of an individual and 
results from the passes of time.  
It is inevitable; thus, it is beyond voluntary control. Extrinsic aging is caused by external 
factors such as smoking, excessive use of alcohol, poor nutrition and sun exposure. 
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This process then is not inevitable and referred as pre mature skin aging. Such 
types of aging are successfully protected by use of functional cosmetics. 
                       
                               
                                                         Figure no: 3 Structure Of Skin 
 
Signs of Intrinsic Aging  
• Fine wrinkles. 
• Thin and transparent skin 
• Loss of underlying fat. 
• Bones shrink away from the skin due to bone loss, which causes sagging skin. 
• Dry skin that may itch. 
• Inability to sweat sufficiently to cool the skin. 
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• Graying hair that eventually turns white. 
• Hair loss. 
• Unwanted hair. 
•Nail plate thins, the half moons disappear and ridges develops. 
Signs of Extrinsic Aging 
•Wrinkles 
•Toxicity. 
•Uneven pigmentation 
•Brown spots and leathery appearance. 
•Chronologically aged skin. 
Other Skin Complications 
• Eczema, also known as atopic dermatitis, is a skin disorder characterized by redness, 
swelling, itching and scaling. 
•Acne is an inflammatory disease of the sebaceous glands and hair follicles of the 
skin that causes pimples or pustules, especially on the face. 
 
Selection of Phytoconstituents/FormulationConsiderations21 
Following are selection criteria’s of phytoconstituent from herbal extract for phytosomes 
preparation and formulation considerations for phytosome development. 
(A) Selection of herbal extracts 
Herbal extracts posses various properties such as photo-protection, hepato-protection, anti-aging, 
moisturizing, and antioxidant, astringent, anti-irritant, and antimicrobial. Because of such 
properties they produces healing, softening, rejuvenating, and sunscreen effect on skin and 
improve pharmacological and pharmacokinetic profile in the body. After detailed literature 
survey of herbs and correlation of activity of herbal compounds based on chemical classes such 
as flavonoids, monoterpenes, polyphenols, indols and organosulfides, one can select herbal 
extracts on the basis of their nature, availability, estimation method, stability and utility of 
developed formulation as well as reported previous research. 
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(B)Nature of phytoconstituents 
Solubility is important criterion for the development of novel formulations. According to the 
nature of the phytoconstituents, that is hydrophilic or lipophilic, best suitable formulation can be 
selected. 
Preparation of phytosomes 22,23 
1 . Solvent Evaporation Method:  
The particular quantity of drug and phospholipids can be taken in a spherical bottom flask and 
reflux with specific solvent at a temperature of 50 to 60˚c for 2 hour . The mixture may be 
concentrated to 5 to 10 ml in order to get a precipitate which can be filtered and collected. The 
dried precipitate phytosome loaded can be placed in amber colored glass bottle and stored under 
room temperature.  
2. Rotary Evaporation Technique: 
The particular quantity of drug and phospholipids can be dissolved in specific solvent in a rotary 
spherical bottom flask followed by stirring for 3 hours at a temperature not exceeding 40˚c . Thin 
film of the sample can be obtained to which a solvent is added and continuously stirred using a 
magnetic stirrer. The precipitate phytosome loaded obtained can be collected placed in amber 
colored glass bottle and stored under room temperature .3. Antisolvent Precipitation 
Technique: 
The particular quantity of drug , phospholipids taken into a spherical bottom flask and reflux 
with specific solvent at a temperature not exceeding 60˚c for 2 hour  .  The mixture can 
concentrated to 5 to 10 ml . Solvent can carefully added with continuous stirring to get 
precipitate which has  filtered  and collected , stored in vacuum desiccators  overnight . The dried 
precipitate is crushed in mortar and sieved through #100 meshes . The dried precipitate 
phytosome loaded can be placed in amber colored glass bottle and stored at room temperature. 
 
Characterization of phytosomes22,15 :-  
1. Determination of % yield: Determination of % yield of phytosome complex was calculated 
by the following formula:  
(%) Yield = (Practical yield) × 100 (Theoretical yield)  
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2. Determination of drug content: Drug content of phytosome complex was determined by 
dissolving accurately weighed quantity of complex in a solvent and after suitable dilution 
absorbance was determined by UV –Spectrophotometer and drug content was determined.  
3. Entrapment efficiency: The entrapment efficiency of a phytosomal formulation can be 
determined by subjecting the formulation to ultracentrifugation technique. 
4. Solubility Studies: Solubility of the drug, phospholipids, their physical mixture and the 
pharmacosomes can be evaluated. The apparent partition coefficient can be determined by the 
shake-flask method where two phases are mutually saturated before use. Equal volumes of buffer 
solutions with a different pH (from 2.0 to 7.4) and 1-octanol containing phospholipid complex 
are mixed properly in the screw capped penicillin bottles and equilibrated under constant shaking 
at 37°C for 24hours. After separating the aqueous phase, the concentration of drug in this 
aqueous phase is determined by HPLC or UV spectrophotometry. 
5. Scanning electron microscopy (SEM): Scanning electron microscopy has been used to 
determine particle size distribution and surface morphology of the complexes.  
6. In-vivo and In-vitro Evaluations  
Depending upon the expected therapeutic activity of biologically active constituents, models of 
in-vivo and in-vitro evaluations are carried out. In-vitro dissolution studies can be done with 
media of different pH in a standard dissolution apparatus to determine the pH dependent 
dissolution profile. 
 
Morinda citrifolia26,27 
Morinda citrifolia L. (Rubiaceae), commonly known as Noni, has been extensively used in folk 
medicine by the Polynesians for over 2000 years. It is having  a broad range of therapeutic 
effects like antiviral, antibacterial, antifungal, antitumor, anthelmintics, analgesic, hypotensive, 
wound healing, anti-inflammatory, anti cancer anti oxidant,  immune enhancing effects.  
Phytochemical investigations have shown that Noni contains a number of phenolic compounds, 
in particular coumarins and flavonoids, and iridoids which are reported to have anti-oxidant, 
anti-inflammatory and neuroprotective effects. But extraction of individual compound from the 
extract often exhibits limited clinical utility as the synergistic effect of various natural 
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ingredients gets lost. They generally constitute polyphenols and flavonoids which show poor 
absorption due to their multiple ring structures unsuitable for passive diffusion or lack of carrier 
mediated transport or poor miscibility in water/lipids. 
Phytosome technology is a breakthrough model for marked enhancement of bioavailability, 
significantly greater clinical benefit, assured delivery to the tissues, and without compromising 
nutrient safety. The water-soluble phytomolecules (mainly flavonoids and other polyphenols) 
can be converted into lipid-friendly complexes, by reacting herbal drugs with phospholipid. They 
are more bioavailable as compared with simple herbal extracts owing to their enhanced capacity 
to cross the lipid-rich biomembranes and, finally, reach in the blood circulation. The 
phospholipid mainly used to make phytosomes, is phosphatidylcholine . Phytosomes are 
prepared from the reaction of a stoichiometric amount of the phospholipid (phosphatidylcholine) 
with the standardized extract or polyphenolic constituents.12 
Based on the above observations, it was concluded to formulate phytosomes of Morinda citrifolia 
extract and evaluated for the improvement in drug loading and drug release. Findings of the 
research are included in this thesis. 
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                       REVIEW OF LITERATURE 
Literature Review About Phytosome 
K. Rajashekar  et  al  (2015) .,41   Prepared and evaluated topical phytosomal gel of Woodfordia 
fruticosa extract (WFE). Dried flowers of the plant were subjected to soxhlation using 80% 
methanol. The extract was complexed with soyalecithin in various drug:lipid ratios of 1:1, 1:2, 
1:3, 1:4 and 1:5. Phytosomal complex of WFE was prepared by Ethanol method and Reflux 
method. All formulations were evaluated for vesicle formation, % yield, Entrapment efficiency 
and in-vitro drug release studies. Drug : lipid ratio of 1:3 (E3) was suitable as it resulted in 
greater entrapment efficiency  and in-vitro drug release  Characterization of phytosomal complex 
(E3) revealed vesicle size and Zeta potential to be 213.1nm and 31.5mv indicating stability of the 
complex. Phytosomal gels of WPC E3 were formulated using different  polymers (Carbopol 934, 
HPMC K4M, HPMC K100) in various concentrations. All gels were evaluated for homogeneity, 
pH, viscosity, drug content and in-vitro drug release studies. In vitro antioxidant activity of 
extract, phytosome and gel are in following order E3>PCG1>WFE. The data obtained in this 
study revealed that the objective has been met. Results of comparative study indicated that better 
solubility, increased antioxidant activity& in vitro drug release of phytosomal gel over crude 
extract. 
Keerthi B et  al  (2014).,42  Formulated and evaluated capsules of Ashwagandha phytosomes. 
Two methods have been attempted in preparing Ashwagandha phytosomes complex  ethanol 
method and reflux method. Ashwagandha phytosomes complex in the ratios of (1:1, 1:2, 1:3, 1:4, 
and 1:5) were prepared using ethanol as a reaction medium. Ashwagandha phytosome complexes 
were characterized by particle size, zeta potential, scanning electron microscopy (SEM), Fourier 
transform infrared spectroscopy and in vitro drug release. The results showed that the average 
particle size and zeta potential of optimized Ashwagandha phytosomes formulation were 98.4nm 
and −28.7 mV. In vitro drug release studies revealed that the cumulative % drug release of 
capsules of Ashwagandha phytosomes was found to be 76.8%. Antioxidant activity of 
Ashwagandha phytosomes was evaluated by reducing power method. The results showed that 
the Ashwagandha phytosome complex exhibited more antioxidant activity compared to the 
Ashwagandha extract. Hence it was concluded that Ashwagandha phytosomes serve as useful 
novel drug delivery system and provide more bioavailability than conventional formulations. 
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 Rudra Pratap Singh et al  (2015).,43 Prepared and evaluated topical phytosomal gel of  
lawsone. Different phytosome complexes of lawsone containing molar ratio of 1:1, 1:2, 2:1 and 
2:2 of lawsone and soya lecithin were prepared by the antisolvent precipitation technique. The 
phytosome was characterized by SEM, DSC and FTIR. Antifungal activity of phytosome of 
lawsone was evaluated on Candida albicans  fungi by using ketoconazole as standard drug. The 
in-vitro permeation study was done on rat skin. The anti-inflammatory activity was evaluated in 
male wistar rats. SEM and DSC data showed that phytosome complex of lawsone has irregular 
size vesicles consisting of soya lecithin and lawsone was found to be intercalated in the lipid 
layer. Antifungal activity of phytosome complex (1:1) showed the biggest zone of inhibition as 
compared to phytosome complex (1:2), plant drug and standard drug ketoconazole after 3 days. 
Ex-vivo permeation study of phytosome gel of lawsone through excised rat skin showed  
cumulative drug permeation up to 6 h. 
 Asit R Sahu et al (2015).,44 Formulated  boswellic acid loaded phytosome . Phytosomal 
formulations were developed using different concentration of Cholesterol (1-3%) and ethanol 
(20-40%) then optimized and characterized. Particle size, entrapment efficiency and vesicular 
shape were determined by Malvern Zetasizer, Ultracentrifugation and Scanning Electron 
Microscopy, respectively. Particle size varied from 179 to 514.8 nm depending on the 
concentrations of Cholesterol and ethanol. Entrapment efficiencies were exhibited of 39.8 ± 
3.7% to 74.2 ± 4.3 %, where it increased with concentration of cholesterol and ethanol increased. 
Photomicrographs revealed that optimized Phytosomes were spherical in shape and uniform in 
size. Based on minimum particle size and maximum entrapment efficiency E6 (2% of 
Cholesterol concentration and 40% of ethanol concentration) was selected as optimization 
Phytosomal formulation. 
Ashwini S Dhase et al (2015).,45 Phytosomes was successfully prepared by solvent extraction 
method. Firstly leaves of A.marmelos were extracted with petroleum ether and methanol by 
soxhlet extraction. Then phytosomes batches were prepared by solvent evaporation method. F3 
formulation selected as optimized formulation and futher evaluated it for particle size digital 
microscopy, SEM, TEM, FTIR, DSC, XRD analysis. Comparative evaluation ofantioxidant, 
antiproliferative and anticancer activity of extract and phytosome was carriedout. From above 
studies we are concluded that phytosomes has better physical characteristics ascompared to that 
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of methanolic extract of leaves of A.marmelos. Phytosomes has nearly same antioxidant, 
antiproliferative and anticancer activity as that of methanolic extract of leaves of A.marmelos. 
 Asija Sangeeta et al (2012).,46 Prosopis cineraria extract in combination with the 
phospholipids was developed to overcome the limitation of absorption and bioavailability and  to 
improve the lipophilic properties of Prosopis cineraria extract. Phytosomes were prepared by 
rotary evaporator method. The physicochemical properties of the phytosomes including infrared 
spectrophotometry, % yield, solubility and apparent partition coefficient were determined. In 
addition, drug content and in vitro dissolution was evaluated. The results of infrared spectra 
showed that there was some interaction between drug (Prosopis cineraria methanolic exract) and 
phospholipid (soya lecithin) in the complex (phytosomes), but no new characteristic absorption 
peaks were observed, indicating that no new covalent bonds were formed. 
 A. Sumathi et al (2015) .,47 Designed and developed phytosomes of  Nymphaea nouchal (Nn) 
and  Trichosanthes dioica (Td),  by reacting phosphatidyl ethanolamine (PE) in tetrahydrofuran 
with the selected botanical derivatives in dioxane:methanol (7:3) solvent system. Different 
Nn/Td:PE molar ratios 1:1, 1:2, 1:4, 1:6, 1:8 and 1:10 were employed using solvent evaporation 
technique. In vitro appraisal encompassed differential calorimetry, infra red spectroscopy, 
particle size, drug content, diffusion and stability studies. The results revealed that the optimized 
phytosomal carriers, PE(Nn/Td) exhibited the mean particle size of 268 nm and good in vitro 
stability in the ratio of 1:8. It also exhibited significant enhancement in diffusion rate compared 
to crude drug mixture and standard (Levimasole). Thus, the phytosomal carrier (PE) with 89 % 
of entrapped drug could be successfully tailored for Nn/Td with improved in vitro release 
characteristics which is promising for increasing drug delivery and decreasing the effect of 
exogenous factors. 
Malay K Das et al (2014).,48 Rutin phytosomes (RN-P) were developed and characterized to 
establish its feasibility for transdermal application in inflammatory conditions. Phytosomes were 
prepared in five molar ratios of Rutin (0.5 - 1.0) to Phosphatidylcholine (1.0 - 0.5). All RN-Ps 
showed aqueous solubility higher than pure Rutin. Partition coefficient results indicated the 
lipophilic nature of free Rutin as well as all RN-Ps with most satisfactory value found at 3.11 ± 
0.08 with F3 formulation. Discrete vesicular structures of RN-Ps observed in TEM study. Results 
of the FT-IR, DSC and XRD studies confirmed the phyto-phospholipid complex formation. XRD 
reports revealed the reduction in crystallinity of Rutin when in phytosomes form with F3 found 
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to be the least crystalline. SEM studies confirmed the disappearance of rod shaped crystals of 
Rutin in phytosome formulations. The ex-vivo skin permeation study across excised rat 
abdominal skin confirmed the higher permeability of RN-Ps (33 ± 1.33 %) over pure Rutin (13± 
0.87 %). The observations made in the present work suggest that phyto-phospholipid complex of 
Rutin can increase its skin uptake to treat inflammatory conditions in arthritis, rheumatism, 
athletic aches and may able to deliver the drug for a long duration avoiding the problems 
associated with oral administration. 
Sandeep Arora et al (2013).,49 Formulated and characterized phytosomal complex tablets for 
sustained delivery of Phyllanthus amarus complex. Phyllanthin, one of the active lignin present 
in this plant species was isolated from the aerial parts, by silica gel column chromatography 
employing gradient elution with hexane–ethyl acetate solvent mixture. It was obtained in high 
yields (1.23%), compared to reported procedures and the purity was ascertained by HPTLC 
analysis. Phyllanthin was characterized for M.P, UV–Visible spectrophotometry, FT-IR, 1H 
NMR, 13C and NMR analysis. Release kinetics was evaluated by using United States 
Pharmacopeia (USP)-22 type I dissolution apparatus. Scanning electron microscopy was used to 
visualize the effect of dissolution medium on matrix tablet surface. HPTLC was carried out for 
quantitative and qualitative estimation of Phyllanthin in Phyllanthus amarus and Rf of 
phyllanthin was found to be about 0.25. The content was found to be maximum for phytosomal 
complex of phyllanthus formed by vaccum drying of 1:1 drug excipient ratio. The in-vitro drug 
release study revealed that optimized formulation sustained the drug release for 12 hr (88.1% ± 
4.1% release). Fitting the in vitro drug release data to Korsmeyer equation indicated that 
diffusion along with erosion could be the mechanism of drug release. 
Diogo Matias et al (2015).,50 Formulated and characterized phytosomes containing a bioactive 
extract from Plectranthus madagascariensis and optimization of the preparation method. 
Different formulations and process parameters were studied. It was observed that smaller and 
more uniform particles were obtained using acetone as solvent, a reaction time of two hours, and 
the addition of 2.5% molar concentration of cholesterol. The optimally prepared phytosomes had 
a diameter of 191.3 ± 75.3 nm with a polydispersity index of 0.243 ± 0.18, and a spherical shape 
with amorphous appearance. These nanosystems were able to encapsulate 92.8% of the extract, 
as evaluated by HPLC, relative to 7α,6β-dihydroxyroyleanona, the main extract component. This 
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study suggests a future application of those phytosomes in the delivery of bioactive agents with 
therapeutic interest. 
Parul A. Ittadwar et al (2016).,51 Umbelliferone was successfully complexed with 
phosphatidylcholine to form phytosome. The preformulation studies confirmed identification of 
umbelliferone. The complex was successfully formulated by solvent evaporation method using 
Box-Behnken experimental design and batch was optimised. The optimised batch was evaluated 
for % practical yield, complexation rate, drug content and the results were within the range. The 
complex showed better solubility than the drug in both phases. The complex was found to show 
higher in vitro antioxidant activity than the drug at the same concentrations. The HPTLC, DSC, 
FT-IR, SEM, XRD and NMR study confirmed the successful formation of the complex. The ex 
vivo and in vitro permeation studies showed better release for phytosomal complex than the drug. 
The animal study was carried out for the photoprotective effect of complex and the effect was 
evaluated by estimating the antioxidant enzymes. The phytosomal complex was better able to 
protect the skin and then antioxidant enzymes than the drug. The stability study revealed that 
there were no significant changes in the formulation over the period of three months. Hence this 
study suggests that umbelliferone in novel drug delivery system i.e. phytosomal form, produces a 
better therapeutic effect than the drug alone. 
Ahmed N.Allam et al (2015).,52 Curcumin phytosomes were prepared by a simple solvent 
evaporation method where free flowing powder was obtained in addition to a newly developed 
semisolid formulation to increase curcumin content in soft gels. Phytosomal powder was 
characterized in terms of drug content and zeta potential. Thirteen different soft gel formulations 
were developed using oils such as Miglyol 812, castor oil and oleic acid, a hydrophilic vehicle 
such as PEG 400 and bioactive surfactants such as Cremophor EL and KLS P 124. Selected 
formulations were characterized in terms of curcumin in vitro dissolution. TEM analysis 
revealed good stability and a spherical, self-closed structure of curcumin phytosomes in complex 
formulations. Stability studies of chosen formulations prepared using the hydrophilic vehicle 
revealed a stable curcumin dissolution pattern. In contrast, a dramatic decrease in curcumin 
dissolution was observed in case of phytosomes formulated in oily vehicles. 
Jadhav S.J. et al (2016).,53 Formulated and characterized phytosomes of Butea monosperma 
phytosome by solvent evaporation technique . Different phytosomal ration of 1:0 , 1:0.8 , 1:1 , 
1:2 were prepared and 1:2 ratio was optimized for the further studies .Phytosome complexes 
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were characterized by particle size, zeta potential, scanning electron microscopy (SEM), Fourier 
transform infrared spectroscopy and in vitro drug release and free radical scavenging activity by 
DPPH model  . In-vitro drug release study of phytosome extended release pattern show 6 hr of 
80.36 release .  The synergistic effect was determined by free radical scavenging activity of BM 
phytosome  using DPPH model . It was concluded that phytosome were successfully prepared 
and encapsulated shows extended release pattern with enchanced free radical scavenging 
activity.  
Alisha Pereira et al (2015).,54 Developed  a phospholipid complex of amla extract that enhances 
the delivery of polyphenols into the skin. The amla extract phytosomes prepared, had an 
entrapment efficiency of 94.03±0.10 %. The characterization studies showed that constituents of 
amla extract successfully formed a complex with phospholipids. The complex was incorporated 
into a cream formulation, which was found to be stable. The ex-vivo diffusion studies of cream 
showed that administration of the amla extract via phospholipid complexes gave better skin 
retention compared to the conventional cream. Thus, phospholipid complex of amla extract gave 
a prolonged antioxidant effect compared to the conventional cream. 
Prasuna Sundari Pingali et al (2015).,55 Formulated and evaluated miconazole loaded topical 
phytosomal gels. This study was mainly based on the  use of phytosome as carrier for drug 
loading of Miconazole(MCZ).  Schrebera root bark extract (SRE) was used to formulate 
miconazole loaded phytosomal complexes (MPC’s). Schrebera swietenioides (Oleaceae) root 
bark methanolic extract  (SRE) was prepared by soxhlation. Miconazole nitrate (MCZ) and SRE 
were complexed using soyalecithin in definite drug:lipid ratios by ethanol method. All 
Miconazole loaded phytosomal complexes were evaluated and characterized for entrapment 
efficiency, in vitro release, vesicle size, vesicle stability and SEM. Blank phytosomes (SRE-
soyalecithin complex) and drug-loaded phytosomes (MCZ loaded SRE phytosomes) were 
included for comparison. Further, the optimised MPC’s were formulated as gels using varying 
polymers in differing concentrations and were assessed for their homogeneity, pH, drug content 
and in vitro permeation using Franz diffusion cell. The optimized formulation F4 was subjected 
to stability studies as per ICH guidelines. Microscopical examination of MPC’s revealed 
spherical shape and uniform size. MP1B and MP6B were optimized based on their in vitro drug 
release profile. The evaluation of prepared phytosomal gels of MP1B and MP6B indicated F4 to 
be better with 93.3 % drug content and 92.54% cumulative drug release of MCZ in 12hrs. 
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Miconazole was successfully loaded into the SRE-phytosomal complex. The results 
demonstrated that other poorly soluble drugs can be further be explored for better therapeutic 
benefit. 
Prasanna Habbu et al (2015).,56 A phytoformulation, Allium cepa-phospholipid complex (ACP)  
was  prepared  and characterized by SEM, DSC and FT-IR. It was then screened for in vitro free 
radical scavenging, antidiabetic activity (50 mg/kg and 100 mg/kg, p.o.) in normoglycemic and 
STZ induced diabetic animals. Concentration of quercetin in ACP was estimated in serum by 
HPLC.  SEM data showed that ACP has irregular size vesicles consisting of HSPC and ACE 
intercalated in the lipid layer. ACP showed one endothermal peak in DSC studies. ACP showed 
good in vitro antioxidant activity. In OGTT, treatment with ACE (Allium cepa extract), ACP and 
glibenclamide significantly improved the glucose tolerance in normal animals. In STZ induced 
diabetic rats, a single dose of ACE and ACP treatment exhibited reduction in SG levels at 
different time intervals compared to basal levels. Administration of both the doses of ACE and 
ACP for fifteen days exhibited greater percentage reduction in glycemia and restored to near 
normal value of all tested lipid parameters. Higher serum concentration of quercetin was 
observed for ACP in bioavailability studies as compared to ACE. The studies revealed that ACP 
has shown significant antioxidant, antidiabetic activity and hypolipidemic activity in STZ 
induced rats as compared to ACE at the dose studied. 
Ruchi Shakya et al (2014).,57 Formulated and characterized phytosome suspension of Urtica 
dioica (UD) . Extraction of Urtica dioica was done by maceration technique using ethanol 
(70%). Formulation of herbosome suspension was done by solvent evaporation technique. 
Phytosme suspension thus formed was evaluated for visualization, particle size, surface tension 
activity, stability, pH. Phytosome suspension appeared irregular spheres shape when seen 
through optical microscope and SEM. Particle size and charge determination of all formulation 
showed size in microns range and possess good stability. FTIR analysis and interpretation of all 
formulation reveals formation of complex and presence of hydrogen bonding, Short term 
stability studies on the most satisfactory formulation F5 was done as per ICH guideline showed 
no or little change in particle size, surface tension, and chemical integrity of suspension before 
and after stability studies. These findings suggest that herbosome suspension of Urtica dioica 
(100 mg/kg) shows better antidiabetic activity in comparisons to the powdered marketed 
formulations of Urtica dioica. 
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Literature Review About Morinda citrifolia 
Saini Jasdeep Kaur et al (2016).,58 Determined the  anti-mycotic activity of commercially 
available Noni extract against Malassezia furfur, lipophilic yeast causing seborrhoeic dermatitis 
and other superficial skin infections. According to the anti-mycotic activity assay carried out 
using well diffusion method, the zone of an inhibition of Noni extract was compared to the zone 
of inhibition of few natural products and standard antidandruff shampoo. It was determined that 
Noni juice showed comparatively higher anti-mycotic activity, thus proving as an effective 
alternative against seborrhoeic dermatitis. 
Afa K. Palu et al (2012).,59  Evaluated the ability of noni  extracts and preparations which   
inhibit MMP, COX-2 and Cat-G enzymes in vitro, as its mechanism of action for healing sun 
burn known as fohia in Tonga. Noni leaf ethanolic extract  inhibited MMP-1, -2, -3, and -9 
enzymes concentration dependently with 0.517, 0.234, 0.184, and 0.302 mg/mL IC50. Noni fruit 
juice concentrates in 1 and 5 mg/mL concentrations, inhibited MMP-12 enzymes by 102, and 
99%, respectively. Both the extract and juice inhibited Cat-G enzymes concentration 
dependently with 0.125, <0.1, and 0.41 mg/mL IC50, respectively which help in the treatment of 
fohia skin . These results warrant further studies into the skin health benefits of noni fruit and 
leaf to further assess their efficacies and dosages in human subjects suffering from photoaging.  
Praveen K. Ramamoorthy et al.,(2007)60 Soxhlet, Ultrasonic and four extracts from high 
pressure extraction at 10 MPa using ethanol, ethyl acetate as solvent of Morinda citrifolia 
L.extract were analyzed for antioxidant activity by peroxide value method and 
diphenylpicrylhydrazyl radical scavenging method. Further five extracts were subjected  to 
determine their total phenolic content by Folin-Ciocalteau method and total flavonoid content by 
Dowd method. The M. citrifolia extract by high pressure extraction was found to exhibit highest 
antioxidant activity and total flavonoid content. High total phenolic content was determined in 
the high pressure extract using ethyl acetate as solvent and vacuum dried. The ultrasonic extract 
exhibited significant antioxidant activity, total phenolic and flavonoid content. High pressure 
extracted M. citrifolia in ethanol was found to express lesser values comparatively. The 
significant difference in activity among the high pressure extracts was found to be due to the 
polarity of the solvents used for extraction as M. citrifolia fruit contains relatively larger quantity 
of non-polar antioxidant compounds. It was also found that the drying methods had significant 
impact on the antioxidant activity, total phenolic and flavonoid content of the extracts. 
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CH. Kethani Devi et al (2013).,61  The petroleum ether and alcoholic extract of Morinda 
citrifolia L. extract  were subjected to preliminary screening for Antimicrobial and Aanthelmintic 
activity. The alcoholic extract exhibited significant Anti-bacterial, Antifungal activity, 
comparable to the standard drug Tetracycline. The Petroleum Ether and Alcoholic extract were 
evaluated for Anthelmintic activity on adult Indian Earthworms, ‘Pheretima posithuma’. The 
Alcoholic extract produced more significant Anthelmintic activity than Petroleum ether extract 
and the activities are comparable with the reference drug Piperazine citrate. 
Afa K. Palu et al (2012).,62 Investigated whether extracts and preparations of noni fruit and leaf  
inhibit MMP, COX-2 and Cat-G enzymes in vitro, as its mechanism of action for healing sun-
burn known as fohia in Tonga. Noni leaf ethanolic extract (NLEE) inhibited MMP-1, -2, -3, and 
-9 enzymes concentration dependently with 0.517, 0.234, 0.184, and 0.302 mg/mL IC50, 
respectively. Noni fruit juice concentrates (NFJC) in 1 and 5 mg/mL concentrations, inhibited 
MMP-12 enzymes by 102, and 99%, respectively. NFJC and NLEE inhibited Cat-G enzymes 
concentration-dependently with 0.125, <0.1, and 0.41 mg/mL IC50, respectively. Noni fruit juice 
fractions 4 and 6 inhibited COX-2 and Cat-G enzymes by 85 and 89%, and 89 and 78%, 
respectively. Additionally, the noni fruit puree and noni leaf has 1.91 mg/g and 5.77 mg/g of 
ursolic acid, respectively. NFJC, and NLEE inhibitory effects on MMP, COX-2 and Cat-G 
enzymes might help explain the traditional usage of the noni fruits and leaves for treatment of 
fohia skin as alluded to by Polynesian traditional healers. These results warrant further studies 
into the skin health benefits of noni fruit and leaf to further assess their efficacies and dosages in 
human subjects suffering from photoaging. 
S. L. Kakad et al (2015).,63 Evaluated the phytochemical, antibacterial and antifungal activities 
of leaf extract of Morinda citrifolia . The antibacterial activity was tested against gram positive 
bacteria Bacillus subtilis, Escherichia coli, Pseudomonas fluroscence and Salmonella typhi using 
disc diffusion method. Methanol extract showed highest zone of inhibition in B. subtilis. The 
antifungal activity was tested against Aspergillus niger, Candida albicans and Daedalea flavida. 
Methanol extract showed highest zone of inhibition in A. niger. The leaf extract noticed 
phytochemicals such as tannin, phenol, alkaloid, flavonoids, glycosides, steroids and terpenoids. 
Both the bacterial and fungal strains were exhibited significant inhibition. Phenol and 
anthraquinone activity was also performed. 
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Mairim Russo Serafini et al (2011).,64 Determined the antioxidant, anti-inflammatory, 
antinociceptive,and antibacterial properties of the aqueous extract from M. citrifolia leaves 
(AEMC). Antioxidant activity was observed against lipid peroxidation, nitric oxide, and 
hydroxyl radicals. The antinociceptive effect of AEMC was observed in the acetic acid–induced 
writhing test at the higher dose. Moreover, AEMC significantly reduced the leukocyte migration 
in doses of 200 and 400 mg/kg and showed mild antibacterial activity. Together, the results 
suggest that properties of M.citrifolia leaf extract should be explored further in order to achieve 
newer tools for managing painful and inflammation conditions, including those related to oxidant 
states. 
Hiroshi Okamoto (2012).,65 Investigated the effect of Morinda citrifolia extract in the treatment 
of psoriasiss by a combination with conventional anti-rheumatism therapy by administering  
4g/day of Morinda citrifolia (Noni) powder together with weekly methotrexate (MTX) . 
Psoriatic skin lesions surprisingly improved significantly .  This is the first report showing the 
possibility of a clinical effect of M. citrifolia on psoriasis .Therefore Noni, together with MTX 
might have unknown immune-modulation effects on skin lesions and arthropathy associated with 
psoriasis.This case also gives us a clue to differentiate between skin lesions and arthropathy in 
terms of their pathogenesis.  
Brett J. West et al (2012).,66 A six week clinical trial of a Morinda citrifolia (noni) based skin 
care regimen was conducted with 49 women, ages 38 to 55 years. Daily application of three 
product formulations to the face and neck resulted in significant reductions in lateral canthal fine 
lines and wrinkles (crow’s feet), as measured by technician scoring and digital image analysis. 
Use of the regimen also improved skin elasticity. No evidence of skin irritation was present in 
any participant at any time during the trial. A study questionnaire revealed that the measured 
improvements were visibly perceptible to more than 90% of the participants. The trial results 
substantiate traditional uses of the noni plant to improve skin health. 
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AIM AND OBJECTIVES 
Morinda citrifolia L. (Rubiaceae), commonly known as Noni, has been extensively used in folk 
medicine by the Polynesians for over 2000 years. It is having a high demand as an alternative 
medicine due to its use as antioxidant, anti fungal , anti bacterial, anti-inflammatory, liver 
protective, anticancer, analgesic, immunomodulatory, anti viral and wound healing effects etc. 
Phytochemical investigations have shown that noni contains a number of phenolic compounds, 
in particular, coumarins , flavonoids, and iridoids which are reported to have various 
pharmacological effects .   
However,  these  phytoconstituents  are poorly absorbed either due to their large molecular size, 
which cannot be absorbed by passive diffusion or due to their poor lipid solubility, thus severely 
limiting their ability to transport across lipid-rich biological membranes, resulting in their poor 
bioavailability. 
Phytosomes are vesicular drug delivery systems which incorporate plant extracts or water soluble 
phytoconstituents into phospholipids to produce lipid compatible molecular complexes. They 
provide better absorption and bioavailability than the conventional herbal extracts. 
 
The aim of the present study was to prepare and evaluate topical phytosomal gel of Woodfordia 
fruticosa with an objective to increase its bioavailability and therapeutic efficacy. 
 
  The objectives of the study are: 
• To formulate   phytosomes containing Morinda citrifolia extract  
•  To characterize the prepared phytosomes using various methods like , entrapment 
efficiency , percentage yield , solubility, drug content , in vitro drug diffusion studies , ex-
vivo  permeation study vesicular shape, and physical stability of phytosomes,  
• To prepare phytosomal gel containing Morinda citrifolia  extract  
• To carry out pH,  spreadability coefficient, extrudability, drug content, rheological 
studies and in-vitro drug diffusion study and drug release kinetic data analysis of the 
optimized formulation of  phytosomal gel containing Morinda citrifolia  extract. 
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• To carry out the stability studies on the optimized formulation of phytosomes as per ICH 
guidelines.  
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PLAN OF WORK 
1. Selection of plant drug . 
2.  Initial phyto chemical screening of the plant extract . 
3.   Determination of λmax. 
4. Construction  of standard calibration curve of  Morinda citrifolia extract  
5.   Formulation of  phytosomes containing Morinda citrifolia extract.  
6.    Evaluation of different physicochemical parameters of ethosomes.  
 Entrapment efficiency 
 Percentage drug content 
 Percentage yield 
 Vesicle shape (SEM) 
  In vitro dissolution studies  
 Ex-vivo permeation study 
7.   Preparation of. phytosomal gel containing Morinda citrifolia  extract  
8.   Evaluation of phytosomal gel. 
 pH 
 Spreadability coefficient 
 Extrudability. 
 Viscosity 
 Drug content 
 In vitro diffusion study 
9. Carry out drug release kinetic data analysis and stability studies of the optimised 
formulation of phytosomes as per ICH guidelines  
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PLANT PROFILE 
                  Morinda citrifolia :28-30  
 BOTANICAL DESCRIPTION 
 The botanical name for the genus was derived from the two Latin words morus,                       
mulberry, and indicus,  Indian,  in reference to the similarity of the fruit of noni to that of 
true   mulberry (Morus alba). The species name indicates the resemblance of the plant 
foliage to that    of some citrus species. 
 Family 
            Rubiaceae (coffee family) 
 Plant Parts  
         • Fruits 
                                           
                                                           Figure no: 4 
 The fruit (technically known as a syncarp) is yellowish white, fleshy, 5–10 cm (2–4 in) 
long, about 3–4 cm (1.2–1.6 in) in diameter, and soft and fetid when ripe. 
                                          
• Flowers  
                                            
                                                          Figure no:5 
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Flowers are perfect, with about 75–90 in ovoid to globose heads. Peduncles are 10–30 
mm 
 (0.4– 1.2 in) long, the calyx a truncated rim. The corolla is white, 5–lobed, the tube 
greenish white, 7–9 mm (0.28–0.35 in) long, the lobes oblong- deltate, approximately 7 
mm (0.28 in) long. There are five stamens, scarcely exserted; the style is about 15 mm 
(0.7 in) long. 
 
 • Leaves  
                                              
                                                               Figure no:6 
 
 Leaves are opposite, pinnately veined, and glossy. Blades are membraneous, elliptic to 
ellipticovate, 20–45 cm (8–18 in) long, 7–25 cm (3.5–10 in) wide, and glabrous. Petioles 
are stout, 1.5–2 cm (0.6– 0.8 in) long. Stipules are connate or distinct, 1–1.2 cm (0.4–0.5 
in) long, the apex entire or 2–3-lobed. 
 
• Seeds 
                                               
                                                                  Figure no:7 
 Seeds have a distinct air chamber, and can retain viability even after floating in water for 
months. 
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 Taxonomical Classification 
 
Botanical Name Morinda citrifolia 
Family Rubiaceae 
Kingdom Plantae 
Subkingdom Rubioideae 
Class Magnoliopsida 
Phylum Magnoliophyta 
Order Rubiales 
Genus Morinda 
Species citrifolia 
Table no:1 
 
 Regional Names  
 
Hindi Baratundi 
Telungu Mogali 
Marathi Nagakunda 
Tamil Nuna 
Malayalam Manavapatta 
Kannada Tagase 
Gujarati Surangi 
Bengali Hurdi 
                                                                    Table no:2 
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 Active constituents 
About 160 phytochemicals have been identified in the noni plant, including phenolic 
compounds, flavonoids , organic acids, and alkaloids. Among the phenolic compounds 
found, the most important are anthraquinones (eg, damnacanthal, morindone, morindin, 
aucubin, asperuloside, and scopoletin). The main organic acids are caproic and caprylic 
acids,  while the principal reported alkaloid is xeronine.   
Minerals account for 8.4% of the dry matter and are mainly potassium, sulfur, calcium, 
and phosphorus, with traces of selenium .   Vitamins have been identified in the fruit, 
mainly ascorbic acid (24 to 158 mg per 100 g dry matter),  and provitamin A.   
Phenolic compounds are the major group of compounds which are scopoletin, 
morindone, alizarin, aucubin, nordamnacanthal, rubiadin, rubiadin-1-methyl ether, and 
other anthraquinone glycosides have been identified.  Damnacanthal is an anthraquinone 
that has been characterized and may have anticarcinogenic properties. Scopoletin is a 
coumarin with analgesic properties as well as an ability to control serotonin levels in the 
body. Other studies have shown that scopoletin may also have antimicrobial and 
antihypertensive effects.   
Another noni component, proxeronine, is the precursor of xeronine, an alkaloid that is 
claimed to combine with human proteins, improving their functionality. About 51 volatile 
compounds have been identified in the ripe fruit, including organic acids (mainly 
octanoic and hexanoic acids), alcohols (3-methyl-3-buten-1-ol), esters (methyl octanoate, 
methyl decanoate), ketones (2-heptanone),  
The potassium content is relatively high (30 to 50 ppm), followed by calcium, sodium, 
and magnesium. Vitamin C content varies from 30 to 155 mg/kg. The polysaccharide 
fraction consists primarily of the pectins homogalacturonan, rhamnogalacturonan I, 
arabinan, and type I and II arabinogalactans.   
Numerous iridoids, with the main compounds asperuloside, asperulosidic acid, and 
deacetylasperulosidic acid . Minor iridoids include deacetylasperuloside, 
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dehydromethoxygaertneroside, epi -dihydrocornin, 6-alpha-hydroxyadoxoside, 
citrifolinin B epimers a and b, and 7-beta-epoxy-8- epi –splendoside  
Flavonol glycosides include rutin, narcissoside, and nicotifloroside. Several known and 
new lignans, such as 3,3′-bisdemethylpinoresinol, americanol A, americanin A, 
americanoic acid A, morindolin, isoprincepin, and balanophonin, have been isolated. The 
coumarin scopoletin has also been identified. Similar to other plant parts, the contain a 
wide spectrum of 1-hydroxyanthraquinones, albeit in much lower concentrations. These 
include novel compounds, such as 2-methoxy-1,3,6-trihydroxyanthraquinone and 5,15-
dimethylmorindol. Finally, miscellaneous compounds, such as J-sitosterol and its 3- O -
glucoside, ursolic acid, and 19-hydroxyursolic acid, cytidine, borreriagenin, and 
epiborreriagenin, iridoidderivative, succinic acid diesters, 4-hydroxy-3-
methoxycinnamaldehyde, J-hydroxypropiovanillone, and vanillin have been isolated.  
Some  essential oils with hexanoic and octanoic acids, paraffin, and esters of ethyl and 
methyl alcohols. Ripe fruits contain n-caproic acid, presumably responsible for the 
distinctive odor, known to attract insects such as Drosophilia sechellia .  Fresh plants 
contain anthraquinones, morindone, and alizarin.  
 Dosing 
30 to 750 mL/day; dosing of 500 mg extract is nontoxic. The appropriate dose of noni 
depends on several factors such as the user's age, health, and several other conditions. At 
this time there is not enough scientific information to determine an appropriate range of 
doses for noni. Keep in mind that natural products are not always necessarily safe and 
dosages can be important. Be sure to follow relevant directions on product labels and 
consult your pharmacist or physician or other healthcare professional before using. 
 Therapeutic Uses  
Noni is one of the most frequently used Hawaiian plant medicines. All plant parts are 
used for a variety of illnesses which  include , anti oxidant , anti inflammatory ,  anti-
arthritic , antibacterial, antifungal , anticancer , anticoagulant , antivirus , antispasmodic , 
immunomodulatory , wound-healing ,  neuroprotective  , treatment for burns ,  sore or 
irritated eyes, styes, conjunctivitis, ocular inflammation , arthritic pain 
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 Toxicology 
Some medications for high blood pressure  like ACE inhibitors , Angiotensin receptor 
blockers   can increase potassium levels in the blood.  Medications that can harm the liver  
can increase the risk of liver damage. Do not take noni if you are taking a medication that 
can harm the liver.  Warfarin (Coumadin) is used to slow blood clotting. Taking noni  
might decrease how well warfarin (Coumadin) works to slow blood clotting. This could 
increase the chance of blood clotting..Noni contains large amounts of potassium. Some 
"water pills" can also increase potassium levels in the body. Taking some "water pills" 
along with noni might cause too much potassium to be in the body. Some "water pills" 
that increase potassium in the body include amiloride (Midamor), spironolactone 
(Aldactone), and triamterene (Dyrenium). 
 Special Precautions & Warnings: 
Pregnancy and breast-feeding :. Historically, noni has been used to cause abortions. It 
is also best to avoid noni if you are breast-feeding. Not enough is known about the safety 
of taking        noni during  breast-feeding. 
Kidney problems : Noni contains large amounts of potassium. This can be a problem, 
especially for people with kidney disease. There is one report of a person with kidney 
disease developing high levels of potassium in the blood after drinking noni juice. Don’t 
use noni if you  have kidney problems. 
High potassium levels : Drinking noni fruit juice might increase potassium levels and 
make them even higher in people with already too much potassium in their body. 
Liver disease : Noni has been linked to several cases of liver damage. Avoid using noni 
if you have liver disease 
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                                           EXCIPIENT PROFILE32-38 
SOYA LECITHIN 
 SYNONYM    
Mixed soybean phosphatides, Ovolecithin, Phospholipon, Soybean phospholipids 
 CHEMICAL NAME 
1,2-diacyl-sn-glycero-3-phosphocholine 
 CHEMICAL STRUCTURE 
 
 
 CHEMICAL COMPOSITION 
Contains 21% phosphatidylcholine, 22% phosphatidylethanolamine and 19% 
phosphatidylinositol, along with other components 
 DESCRIPTION 
Lecithins vary greatly in their physical form, from viscous semi liquids to powders, 
depending upon the free fatty acid content. They may also vary in colour from brown to 
light yellow, depending upon whether they are bleached or unbleached or on the degree 
of purity. 
 FUNCTIONAL CATEGORY 
 Emollient, emulsifying agent and solubilising agent 
 SOLUBILITY 
Soluble in aliphatic and aromatic hydrocarbons, halogenated hydrocarbons, mineral oil, 
and fatty acids. Sparingly soluble in ethanol (95%). They are practically insoluble in cold 
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vegetable and animal oils, polar solvents, and water. When mixed with water, however, 
lecithins hydrate to form emulsions. 
 DENSITY 
0.5 g/cm3 
 ISOELECTRIC POINT 
3.5 
 COMPATIBILITY 
Incompatible with esterases owing to hydrolysis 
 STABILITY 
Lecithins decompose at extreme pH. They are also hygroscopic and subject to microbial 
degradation. When heated, lecithins oxidize, darken, and decompose. Temperatures of 
160–180oC will cause degradation within 24 hours. 
 FLAMMABILITY 
Low 
 MOISTURE CONTENT      
Are hygroscopic 
 SPECIFIC GRAVITY 
0.97 g/cm3 
 SAFETY 
 Is non-toxic, but excessive consumption may be harmful. 
 STORAGE 
Should be stored in well-closed containers protected from light, moisture and oxidation. 
Purified solid lecithins should be stored in tightly closed containers at subfreezing 
temperatures 
 APPLICATIONS 
 Lecithins are used in a wide variety of pharmaceutical applications like 
aerosol inhalations, IM injections and oral suspension and are also used in 
cosmetics and food products. 
 Lecithins are mainly used in pharmaceutical products as dispersing, 
emulsifying, and stabilizing agents, and are included in intramuscular and 
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intravenous injections, parenteral nutrition formulations, and topical 
products such as creams and ointments. 
 Lecithins are also used in suppository bases to reduce the brittleness of 
suppositories, and have been investigated for their absorption-enhancing 
properties in an intranasal insulin formulation. 
 Lecithins are also commonly used as a component of enteral and 
parenteral nutrition formulations. Lecithin is a required component of 
FDA-approved infant formulas. 
 Therapeutically, lecithin and derivatives have been used as a pulmonary 
surfactant   in the treatment of neonatal respiratory distress syndrome 
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DICHLOROMETHANE 
 SYNONYM  
Methyelene chloride ,  Solmethine , Narkotil , Solaesthin ,      Refrigerant-30- Freon -30     
    CHEMICAL STRUCTURE 
 
 
 
 MOLECULAR FORMULA 
CH2Cl2 
 MOLAR MASS 
84.93 g.mol -1 
 APPEARANCE 
Colourless liquid 
 ODOR 
  Chloroform like 
 DENSITY 
1.3266 g/cm3 
 VISCOSITY 
0.437mPa.s at 20˚C 
 MELTING POINT 
-96.7˚C 
 BOLING POINT 
39.6˚C 
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 SOUBILITY 
Soluble in water and miscible in ethyl acetate , alcohol , hexanes , benzene , diethyl ether 
 STORAGE 
Store in well- closed container in a cool, dry place. 
 APPLICATION 
 Its volatility and ability to dissolve a wide range of organic compounds 
makes it a  useful solvent for many chemical processes. 
 It is widely used as a paint stripper and a degreaser. 
 In the food industry, it has been used to decaffeinate coffee and tea as 
well as to prepare extracts of hops and other flavorings. 
 Its volatility has led to its use as an aerosol spray propellant and as a 
blowing agent for polyurethane foams. 
 Used as a process solvent in the manufacture of pharmaceuticals . 
 Used as an extraction solvent for spice oleoresin, removal of caffeine 
from coffee. 
 It is also used as a post harvest fumigant for grains. 
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ETHANOL 
 SYNONYM 
Absolute alcohol, Ethyl alcohol , Grain alcohol, Methylcarbinol, Anhydrol, Cologne 
spirit, Ethylic alcohol 
 CHEMICAL NAME 
Ethanol 
 CHEMICAL FORMULA 
C2H6O 
 MOLECULAR WEIGHT 
46.07g.mol-1 
 CHEMICAL STRUCTURE 
 
 APPEARANCE 
Colorless liquid 
 ODOR 
Colorless liquid with weak, ethereal, vinous odor 
 TASTE 
Burning 
 BOILING POINT 
78.29˚C 
 MELTING POINT 
-114.14˚C 
 
 
                                                                                                                               Excipient Profile 
 
Dept of Pharmaceutics, KMCH College of Pharmacy Page 42 
 
 SOLUBILITY 
Miscible with ethyl ether, acetone, chloroform and soluble in benzene. 
 DENSITY 
0.7893 g/cu cm 
 SURFACE TENSION 
21.97 mN/m 
 IONIZATION POTENTIAL 
10.47 eV  
 pKa  
15.9 
 STORAGE 
Store in well- closed container in a cool, dry place. 
 APPLICATIONS 
 Ethanol is used in medical wipes and most common antibacterial hand 
sanitizer gels as an antiseptic. Ethanol kills organisms 
by denaturing their proteins and dissolving their lipids and is effective 
against most bacteria and fungi, and many viruses. However, ethanol is 
ineffective against bacterial spores. 
 Ethanol may be administered as an antidote to methanol[23] and ethylene 
glycol poisoning.  
 used to dissolve many water-insoluble medications and related 
compounds.  
 As a central nervous system depressant, ethanol is one of the most 
commonly consumed psychoactive drugs. 
 The largest single use of ethanol is as an engine fuel and fuel additive.. 
 Ethanol is miscible with water and is a good general purpose solvent. It 
is found in paints, tinctures, markers, and personal care products such as 
mouthwashes, perfumes and deodorants.  
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CARBOPOL 934 
 SYNONYMS 
Acrypol, acryli acid polymer, carbomer, poly acrylic acid, carboxyvinyl polymer, 
carboxy poly methylene, tego carbomer 
 
 NON-PROPRIETRY NAME 
BP : Carbomer 
PhEur: Carbomers 
USP-NF: Carbomers 
 CHEMICAL NAME 
Polyacrylate – 1 – cross polymer 
 MOLECULAR WEIGHT 
Approx. 500,000 to 4,000,000. g 
 CHEMICAL STRUCTURE 
 
 
 
 COLOUR 
White, light, acidic, hygroscopic powder. 
 PARTICLE SIZE 
Flocculated powder having a median diameter of 2 to 7 microns. 
 TOTAL SOLID 
100% 
 DENSITY 
Approximately208kg/m2 
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 SPECIFIC  GRAVITY 
1.41 
 MOISTURE CONTENT 
2.0% maximum 
 VISCOSITY 
           Between 30500 and 39400 centipoise 
 SOLUBILITY 
They are insoluble due to their cross linked nature and high molecular weight. 
 pKa 
6.0 
 SWELLING PROPERTIES 
They get swell in water and some polar solvents, producing viscous dispersions . 
 WETTING TIME 
3 minute 
 PACKING AND STORAGE 
Preserve in tight containers 
 ADVANTAGES 
 Good  rheological properties on the application site. 
 Substitute to oil-based ointment formulations 
 Viscosity is high at low concentration 
 Compatibility 
 Better bioadhesive properties 
 Good thermal stability 
 APPLICATION 
 Very well suited to aqueous formulations of the topical dosage forms such 
as  hydrogel. Many commercial topical products available today have been 
formulated with these polymers. They provide the following plentiful 
advantage to topical formulations 
 Long antiquity of safe and effective use in topical gels, creams and 
ointments. They are also supported by board toxicology studies . 
 Good tablet flow property. 
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 Shows  extremely low irritancy properties and are non-sensitizing with 
repeat       usage. 
 Long drug release. 
 Provides a magnificent vehicle for drug delivery. Due to their high 
molecular weight, they are not able to penetrate the skin or affect the 
therapeutic efficacy of the drug. 
 Superior thickening, suspending, & emulsification properties for topical 
preparations. Products with a wide range of viscosities and flow properties 
have been successfully formulated and commercialized. 
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TRIETHANOLAMINE 
 SYNONYMS 
   s 2-        t    am         t     am         am     2 2  2   -Trihydroxytriethylamine 
 CHEMICAL STRUCTURE 
 
 
 
 CHEMICAL NAME 
      2 2  2   -Nitrilotri(ethan-1-ol) 
 CHEMICAL FORMULA 
C6H15NO3 
 MOLECULAR WEIGHT 
149..19 g.mol 
 APPERANCE 
Coloress viscous hygroscopic liquid or crystals with characteristics odor 
 ODOR 
Ammonical 
 pH 
10.5 Strong base 
 DENSITY 
1.124 g mL-1 
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 VISCOSITY 
65.7 cP 
 SOLUBILITY 
Miscible with water, methanol, acetone soluble in benzene, ether, carbon tetra chloride, 
n-heptane 
 MELTING POINT 
21.60˚C 
 BOILING POINT 
333.40˚C 
 VAPOR PRESSURE 
1 Pa  20˚C  
 PKa 
7.74 
 PACKING AND STORAGE 
Preserve in tight containers 
 APPLICATIONS 
 Triethanolamine is used primarily as an emulsifier and surfactant. 
 The triethanolamine neutralizes fatty acids, adjusts 
and buffers the pH, and solubilizes oils and  other ingredients that are 
not completely soluble in water. 
 Some common products in which triethanolamine is found are 
liquid laundry detergents, dishwashing liquids, general cleaners, hand 
sanitizers, polishes and organic additive (0.1 wt%) in the grinding 
of cement clinker. 
 It  is an active ingredient of some eardrops used to treat impacted 
earwax. 
 It also serves as a pH balancer in many different cosmetic products, 
ranging from cleansing creams and milks, skin lotions, eye 
gels, moisturizers, shampoos, shaving foams, and so on. 
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 Used as a complexing agent for aluminium ions in aqueous 
solutions. 
 2-3% in water triethanolamine is used as an corrosion inhibitor 
(anti-rust) agent in immersion ultrasonic testing. 
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                                           EXCIPIENT PROFILE32-38 
SOYA LECITHIN 
 SYNONYM    
Mixed soybean phosphatides, Ovolecithin, Phospholipon, Soybean phospholipids 
 CHEMICAL NAME 
1,2-diacyl-sn-glycero-3-phosphocholine 
 CHEMICAL STRUCTURE 
 
 
 CHEMICAL COMPOSITION 
Contains 21% phosphatidylcholine, 22% phosphatidylethanolamine and 19% 
phosphatidylinositol, along with other components 
 DESCRIPTION 
Lecithins vary greatly in their physical form, from viscous semi liquids to powders, 
depending upon the free fatty acid content. They may also vary in colour from brown to 
light yellow, depending upon whether they are bleached or unbleached or on the degree 
of purity. 
 FUNCTIONAL CATEGORY 
 Emollient, emulsifying agent and solubilising agent 
 SOLUBILITY 
Soluble in aliphatic and aromatic hydrocarbons, halogenated hydrocarbons, mineral oil, 
and fatty acids. Sparingly soluble in ethanol (95%). They are practically insoluble in cold 
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vegetable and animal oils, polar solvents, and water. When mixed with water, however, 
lecithins hydrate to form emulsions. 
 DENSITY 
0.5 g/cm3 
 ISOELECTRIC POINT 
3.5 
 COMPATIBILITY 
Incompatible with esterases owing to hydrolysis 
 STABILITY 
Lecithins decompose at extreme pH. They are also hygroscopic and subject to microbial 
degradation. When heated, lecithins oxidize, darken, and decompose. Temperatures of 
160–180oC will cause degradation within 24 hours. 
 FLAMMABILITY 
Low 
 MOISTURE CONTENT      
Are hygroscopic 
 SPECIFIC GRAVITY 
0.97 g/cm3 
 SAFETY 
 Is non-toxic, but excessive consumption may be harmful. 
 STORAGE 
Should be stored in well-closed containers protected from light, moisture and oxidation. 
Purified solid lecithins should be stored in tightly closed containers at subfreezing 
temperatures 
 APPLICATIONS 
 Lecithins are used in a wide variety of pharmaceutical applications like 
aerosol inhalations, IM injections and oral suspension and are also used in 
cosmetics and food products. 
 Lecithins are mainly used in pharmaceutical products as dispersing, 
emulsifying, and stabilizing agents, and are included in intramuscular and 
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intravenous injections, parenteral nutrition formulations, and topical 
products such as creams and ointments. 
 Lecithins are also used in suppository bases to reduce the brittleness of 
suppositories, and have been investigated for their absorption-enhancing 
properties in an intranasal insulin formulation. 
 Lecithins are also commonly used as a component of enteral and 
parenteral nutrition formulations. Lecithin is a required component of 
FDA-approved infant formulas. 
 Therapeutically, lecithin and derivatives have been used as a pulmonary 
surfactant   in the treatment of neonatal respiratory distress syndrome 
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DICHLOROMETHANE 
 SYNONYM  
Methyelene chloride ,  Solmethine , Narkotil , Solaesthin ,      Refrigerant-30- Freon -30     
    CHEMICAL STRUCTURE 
 
 
 
 MOLECULAR FORMULA 
CH2Cl2 
 MOLAR MASS 
84.93 g.mol -1 
 APPEARANCE 
Colourless liquid 
 ODOR 
  Chloroform like 
 DENSITY 
1.3266 g/cm3 
 VISCOSITY 
0.437mPa.s at 20˚C 
 MELTING POINT 
-96.7˚C 
 BOLING POINT 
39.6˚C 
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 SOUBILITY 
Soluble in water and miscible in ethyl acetate , alcohol , hexanes , benzene , diethyl ether 
 STORAGE 
Store in well- closed container in a cool, dry place. 
 APPLICATION 
 Its volatility and ability to dissolve a wide range of organic compounds 
makes it a  useful solvent for many chemical processes. 
 It is widely used as a paint stripper and a degreaser. 
 In the food industry, it has been used to decaffeinate coffee and tea as 
well as to prepare extracts of hops and other flavorings. 
 Its volatility has led to its use as an aerosol spray propellant and as a 
blowing agent for polyurethane foams. 
 Used as a process solvent in the manufacture of pharmaceuticals . 
 Used as an extraction solvent for spice oleoresin, removal of caffeine 
from coffee. 
 It is also used as a post harvest fumigant for grains. 
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ETHANOL 
 SYNONYM 
Absolute alcohol, Ethyl alcohol , Grain alcohol, Methylcarbinol, Anhydrol, Cologne 
spirit, Ethylic alcohol 
 CHEMICAL NAME 
Ethanol 
 CHEMICAL FORMULA 
C2H6O 
 MOLECULAR WEIGHT 
46.07g.mol-1 
 CHEMICAL STRUCTURE 
 
 APPEARANCE 
Colorless liquid 
 ODOR 
Colorless liquid with weak, ethereal, vinous odor 
 TASTE 
Burning 
 BOILING POINT 
78.29˚C 
 MELTING POINT 
-114.14˚C 
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 SOLUBILITY 
Miscible with ethyl ether, acetone, chloroform and soluble in benzene. 
 DENSITY 
0.7893 g/cu cm 
 SURFACE TENSION 
21.97 mN/m 
 IONIZATION POTENTIAL 
10.47 eV  
 pKa  
15.9 
 STORAGE 
Store in well- closed container in a cool, dry place. 
 APPLICATIONS 
 Ethanol is used in medical wipes and most common antibacterial hand 
sanitizer gels as an antiseptic. Ethanol kills organisms 
by denaturing their proteins and dissolving their lipids and is effective 
against most bacteria and fungi, and many viruses. However, ethanol is 
ineffective against bacterial spores. 
 Ethanol may be administered as an antidote to methanol[23] and ethylene 
glycol poisoning.  
 used to dissolve many water-insoluble medications and related 
compounds.  
 As a central nervous system depressant, ethanol is one of the most 
commonly consumed psychoactive drugs. 
 The largest single use of ethanol is as an engine fuel and fuel additive.. 
 Ethanol is miscible with water and is a good general purpose solvent. It 
is found in paints, tinctures, markers, and personal care products such as 
mouthwashes, perfumes and deodorants.  
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CARBOPOL 934 
 SYNONYMS 
Acrypol, acryli acid polymer, carbomer, poly acrylic acid, carboxyvinyl polymer, 
carboxy poly methylene, tego carbomer 
 
 NON-PROPRIETRY NAME 
BP : Carbomer 
PhEur: Carbomers 
USP-NF: Carbomers 
 CHEMICAL NAME 
Polyacrylate – 1 – cross polymer 
 MOLECULAR WEIGHT 
Approx. 500,000 to 4,000,000. g 
 CHEMICAL STRUCTURE 
 
 
 
 COLOUR 
White, light, acidic, hygroscopic powder. 
 PARTICLE SIZE 
Flocculated powder having a median diameter of 2 to 7 microns. 
 TOTAL SOLID 
100% 
 DENSITY 
Approximately208kg/m2 
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 SPECIFIC  GRAVITY 
1.41 
 MOISTURE CONTENT 
2.0% maximum 
 VISCOSITY 
           Between 30500 and 39400 centipoise 
 SOLUBILITY 
They are insoluble due to their cross linked nature and high molecular weight. 
 pKa 
6.0 
 SWELLING PROPERTIES 
They get swell in water and some polar solvents, producing viscous dispersions . 
 WETTING TIME 
3 minute 
 PACKING AND STORAGE 
Preserve in tight containers 
 ADVANTAGES 
 Good  rheological properties on the application site. 
 Substitute to oil-based ointment formulations 
 Viscosity is high at low concentration 
 Compatibility 
 Better bioadhesive properties 
 Good thermal stability 
 APPLICATION 
 Very well suited to aqueous formulations of the topical dosage forms such 
as  hydrogel. Many commercial topical products available today have been 
formulated with these polymers. They provide the following plentiful 
advantage to topical formulations 
 Long antiquity of safe and effective use in topical gels, creams and 
ointments. They are also supported by board toxicology studies . 
 Good tablet flow property. 
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 Shows  extremely low irritancy properties and are non-sensitizing with 
repeat       usage. 
 Long drug release. 
 Provides a magnificent vehicle for drug delivery. Due to their high 
molecular weight, they are not able to penetrate the skin or affect the 
therapeutic efficacy of the drug. 
 Superior thickening, suspending, & emulsification properties for topical 
preparations. Products with a wide range of viscosities and flow properties 
have been successfully formulated and commercialized. 
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TRIETHANOLAMINE 
 SYNONYMS 
   s 2-        t    am         t     am         am     2 2  2   -Trihydroxytriethylamine 
 CHEMICAL STRUCTURE 
 
 
 
 CHEMICAL NAME 
      2 2  2   -Nitrilotri(ethan-1-ol) 
 CHEMICAL FORMULA 
C6H15NO3 
 MOLECULAR WEIGHT 
149..19 g.mol 
 APPERANCE 
Coloress viscous hygroscopic liquid or crystals with characteristics odor 
 ODOR 
Ammonical 
 pH 
10.5 Strong base 
 DENSITY 
1.124 g mL-1 
 
 
                                                                                                                               Excipient Profile 
 
Dept of Pharmaceutics, KMCH College of Pharmacy Page 47 
 
 VISCOSITY 
65.7 cP 
 SOLUBILITY 
Miscible with water, methanol, acetone soluble in benzene, ether, carbon tetra chloride, 
n-heptane 
 MELTING POINT 
21.60˚C 
 BOILING POINT 
333.40˚C 
 VAPOR PRESSURE 
1 Pa  20˚C  
 PKa 
7.74 
 PACKING AND STORAGE 
Preserve in tight containers 
 APPLICATIONS 
 Triethanolamine is used primarily as an emulsifier and surfactant. 
 The triethanolamine neutralizes fatty acids, adjusts 
and buffers the pH, and solubilizes oils and  other ingredients that are 
not completely soluble in water. 
 Some common products in which triethanolamine is found are 
liquid laundry detergents, dishwashing liquids, general cleaners, hand 
sanitizers, polishes and organic additive (0.1 wt%) in the grinding 
of cement clinker. 
 It  is an active ingredient of some eardrops used to treat impacted 
earwax. 
 It also serves as a pH balancer in many different cosmetic products, 
ranging from cleansing creams and milks, skin lotions, eye 
gels, moisturizers, shampoos, shaving foams, and so on. 
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 Used as a complexing agent for aluminium ions in aqueous 
solutions. 
 2-3% in water triethanolamine is used as an corrosion inhibitor 
(anti-rust) agent in immersion ultrasonic testing. 
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                                       MATERIALS AND METHODS 
Table 3: LIST OF EXCIPIENTS USED AND THEIR SOURCES 
Sl.No MATERIAL SOURCES 
1 Soya lecithin HiMedia Laboratories, Nashik 
2 Dichloromethane Loba Chemie, Mumbai 
3 Ethanol Changshu Yangyuan Chemical China 
4 Hydrochloric acid SD Fine Chem Ltd, Mumbai 
5 Carbopol 934    Loba Chemie, Mumbai 
6 Triethanolamine SD fine chemicals , Mummbai 
7 Propyl Paraben HiMedia Laboratories, Nashik 
 
Table 4: LIST OF EQUIPMENTS USED 
Sl.No EQUIPMENTS SUPPLIERS / MANUFACTURES 
1 Rotary vaccum evaporator Superfit, India 
2 Weighing balance Shimadzu, Shimadzu corporation, Philippines 
3 Heating mantle Sunbim, India 
4 Viscometer  Brookfield Viscometer , USA 
 5 Sonicator Life Care 
 6 Dissolution apparatus Tab machines, Mumbai, India 
 7 Magnetic Stirrer Remi ,Mumbai 
 8 Centrifuge Apparatus Remi , Mumbai 
 9 Stability chamber Technico, Chennai, India 
  10 Digital pH meter EUTECH Instruments, India 
11 Scanning electron 
microscope 
JEOL, Japan 
 
 
 
                                                                                                                       Materials and Method 
 
Dept of Pharmaceutics, KMCH College of Pharmacy Page 50 
 
PREPARATION OF PLANT  EXTRACT31 
The leaves of plant was air-dried until dryness at room temperature and under shade. The dried 
leaves was then powdered to a fine grade by using laboratory scale mill. Further it was 
sequentially extracted successively with ethanol using soxhlet apparatus. The solvent was 
removed and concentrated in a rotary evaporator and water bath.  The dried extracts were stored 
in refrigerator for  further studies.40,43 
DETERMINATION OF λmax  
The stock solution of 1000μg/ml was prepared by dissolving approximately100mg of pure 
Morinda citrifolia extract in 100ml of pH 7.4 phosphate buffer. From the stock solution, 10ml 
was taken and was further diluted to 100ml with the buffer solution. The prepared solution was 
then scanned in a wavelength range of 200-400nm, to find the maximum absorbance. The 
maximum wavelength was found to be 279nm and was used for further studies. 
DETERMINATION OF STANDARD CURVE  
The serially diluted stock solution was obtained in the range of 2- 10µg/ml by taking 0.2, 0.4, 
0.6, 0.8 and 1 ml from the stock solution, into 100ml volumetric flask. 
 The final solution is made by using phosphate buffer of pH 7.4. 
 The serially diluted solutions were measured in a UV spectrometer at 279nm of the drug. 
 The calibration curve was plotted by taking absorbance on Y-axis and concentration in 
µg/ml on X-axis, to find the slope. 
FORMULATION OF PHYTOSOMES OF Morinda citrifolia   EXTRACT BY   
ANTISOLVENT PRECIPITATION TECHNIQUE42  
To prepare the phytosomes of Morinda citrifolia extract ,  drug extract and soya lecithin at molar 
ratio of 1:1, 1:2 ,1:3 , 1:4 , 1:5 , 1:6 and 1:7 were taken in the flask of vacuum rotary evaporator. 
Dichloromethane  were added in the flask. The mixture was shaken at a temperature not 
exceeding 40˚C for 2 hours. The resultant  solution was evaporated by increasing temperature up 
to 60˚C and by using vacuum pump in vacuum rotary evaporator. Ethanol was added to the flask 
with continuous stirring. The phytosomes was precipitated and ethanol was evaporated under 
vacuum to remove the traces of solvent. The dried residues were gathered and placed desiccators 
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over night, than crushed in the mortar and sieved through 80 mesh then subjected to further 
characterization.34  
                     Table 5: Formulation table of Morinda citrifolia phytosome 
 
Ingredients 
 
F1 
 
F2 
 
F3 
 
F4 
 
F5 
 
F6 
 
F7 
Morinda citrifolia : 
Soyalecithin 
1:1 1:2 1:3 1:4 1:5 1:6 1:7 
Dichloromethane 
(ml) 
20 20 20 20 20 20 20 
Ethanol (ml) 5 5 5 5 5 5 5 
 
EVALUATION  OF PHYTOSOMAL COMPLEX 
1 . Microscopic view55 
Optical microscopy was used for characterization of the complex. The complex was suspended 
in buffer and a drop was placed on a slide and covered with a cover slip. Microscopic view of the 
complex was observed at a magnification of 45X. 
 
 2. Percentage Practical Yield43 
 
Percentage practical yield was calculated to know about percent yield or efficiency of any 
method, thus its help in selection of appropriate method of production. Phytosomes prepared 
were collected and weighed to determine practical yield from the following equation: 
 
(%) Yield = (Practical yield) × 100                                                                                     ..........(1) 
                   (Theoretical yield) 
 
3. Entrapment efficiency41 
100 mg of Morinda citrifolia phytosomal complex were centrifuged at 2000rpm for 30 min using 
a Remi centrifuge to separate phytosomes from un entrapped drug. Concentration of the free 
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drug as the supernatant was determined by measuring absorbance at 279nm using UV-Visible 
spectrophotometer. The percentage drug entrapment was calculated by using the formula, 
Entrapment efficiency (%) = (Total amount of drug) – (amount of free drug)  × 100  
                                                                       (Total amount of drug                                ……....(2) 
4. Drug content55 
Phytosomes equivalent to 10 mg of drug was accurately weighed and taken into a 100 ml 
volumetric flask. The contents of the flask was dissolved in small quantity of ethanol and 
sonicated for 30 minute. Volume was adjusted to 100 ml with ethanol. Contents of the flask were 
filtered and drug content was determined spectrophotometrically using UV spectrophotometer 
after appropriate dilutions.  
5. Solubility Determination55 
To determine the change in solubility due to complexation, the apparent solubility of drug  
extract  and  phytosomal complex was determined by adding an excess amount of drug and 
phytosomes to 6 ml distilled water, 7.4 pH phosphate buffer and n-octanol in screw capped vials. 
The vials were then shaken at 25ºC for 24 hr in a water bath. After equilibrium had been 
attained, the saturated solutions obtained were centrifuged to remove the excess drug (15 min, 
1000 rpm). The supernatant was filtered immediately and rapidly and diluted suitably with same 
solvent to prevent crystallization. The filtered and diluted solutions were then analyzed 
spectrophotometrically at 279 nm. 
6.  In-vitro  Drug Diffusion Study Through Egg Membrane55  
Preparation of egg membrane: From local department store egg was purchased. The egg yolk 
was separated carefully by means of hole on the surface of the egg. After that the egg shell was 
immersed in 0.1N HCl for 2 hours with constant stirring followed by the complete separation of 
egg membrane. The membrane was washed with phosphate buffer of pH 7.4 and further used for 
the experimental work. 
Drug diffusion through egg membrane: The in-vitro diffusion study was done by using Franz 
Diffusion Cell.  The egg membrane was mounted between the donor and receptor compartment. 
The receptor compartment was filled with 15 ml of pH 7.4 phosphate buffer maintained at 37˚C  
and was constantly stirred   by using  a magnetic stirrer. 1g of phytosome  were  placed on the 
egg membrane. At each sampling interval, samples were withdrawn for a period of 1 hours and 
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were replaced by equal volumes of fresh receptor fluid to maintain sink condition. Withdrawn 
samples were analyzed spectrophotometrically at 279nm 
7. Ex-vivo Skin  Permeation Study55(optimized batch) 
The permeation of Morinda citrifolia extract from phytosomal complex was investigated by 
using in-vitro Franz Diffusion Cell . The abdominal chicken kin was obtained from slaughter 
house and adhering subcutaneous fat was carefully cleaned. To remove the extraneous debris and 
leachable enzymes, the dermal side of the skin was kept in contact with physiological saline 
solution for 1 hour before starting the permeation experiment. 
The skin was mounted on the receptor compartment with the stratum corneum facing towards the 
donor compartment. The receptor compartment was filled with 15 ml of pH 7.4 phosphate buffer 
maintained at 37˚C and was constantly stirred  a magnetic stirrer. 1g of phytosome were  placed 
on the skin in the donor compartment. At each sampling interval, samples were withdrawn for a 
period of 10 hours and were replaced by equal volumes of fresh receptor fluid to maintain sink 
condition. Withdrawn samples were analyzed spectrophotometrically at 279nm. 
 8. Scanning Electron Microcopy (SEM) Analysis46 
To detect the surface morphology of the phytosome, SEM of complex was performed by 
Scanning Electron Microscope JSM 6390 (JEOL, Japan) at STIC, Cochin University, Ernakulam 
. The powder samples of phytosomes was sprinkled onto the tape. The aluminum stubs were 
placed in the vacuum chamber of scanning electron microscope. The sample was observed for 
morphological characterization using secondary electron detector attached to scanning electron 
microscopy. 
FORMULATION OF GELS OF PHYTOSOME COMPLEX43 
• Preparation of gel: Gel bases were prepared by separately dispersing Carbopol 934 in 
distilled water  with constant stirring at a moderate speed using mechanical shaker. The 
pH of all the formulations was adjusted to 5.5 - 6.5 using triethanolamine 
• Incorporation of Phytosomal complex into the gel: The solution of phytosome 
complex was prepared in 0.1 ml of ethanol in another beaker and was added to the 
Carbopol base. Different formulations were prepared using varying concentration of 
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gelling agent. Prepared gels were stored  in suitable containers at room temperature for 
further studies.  
                    Table No:6 Formulation of  Gels of Phytosome Complex 
Ingredients F1 F2 F3 F4 F5 F6 
Carbopol 934 1% 1.5% 2% 2.5% 3% 3.5% 
Triethanolamine q.s q.s q.s q.s q.s q.s 
Propyl paraben 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 
Ethanol 1% 1% 1% 1% 1% 1% 
Distilled Water q.s q.s q.s q.s q.s q.s 
 
EVALUATION OF GELS OF PHYTOSOME COMPLEX 
1. Homogeneity55 
All developed gels were tested for homogeneity by visual inspection after the gels have been set 
in the container .They were tested for their appearance and presence of any aggregates. 
2.  Measurement of pH41 
The pH of the phytosome gels were measured with the help of digital pH meter. 0.5 g of 
phytosome gel was dissolved in 50 ml of distilled water and stored for two hrs. The measurement 
of pH of each formulation was determined. 
3. Drug content43 
1 g of the prepared gel was mixed with 100ml of suitable solvent. Aliquots of different 
concentration were prepared by suitable dilutions after filtering the stock solution and 
absorbance was measured at 279 nm. 
4. Rheological study41 
The measurements of viscosity of prepared gels were carried out with Brookfield Viscometer 
(spindle type S–96). The readings of each formulation were taken. 
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5. Spreadability43 
On a glass plate of 10×5cm, 350mg emulgel was taken and another plate of same sized was 
dropped from a distance of 5cm. After 1 minute the diameter of the circle spread was measured. 
6. Extrudability43 
In the present study, extrudability was determined by measuring the weight (in grams) required 
to extrude at least 0.5cm gel from lacquered aluminum collapsible tube in 10 sec . The 
extrudability was then calculated by using the following equation: 
Extrudability = Applied weight to extrude gel from tube (in gram) 
                                                       Area( in cm2)                                                                                      ………(3) 
7. In-vitro drug release study55 
The in-vitro rug release studies were carried out using a modified Franz diffusion (FD) cell. The 
formulation was applied on egg membrane which was placed between donor and receptor 
compartment of the FD cell. Phosphate buffer pH 5.5 was used as diffusion media. The 
temperature of the cell was maintained at 37˚C. The whole assembly was kept on a magnetic 
stirrer and the solution was stirred continuously using a magnetic bead. One ml of aliquots were 
withdrawn from the diffusion medium at specific time interval for 12 hours and same quantity of 
fresh , pre-warmed diffusion medium was replaced for the amount withdrawn. The samples 
withdrawn were analyzed spectrophotometrically at 279 nm and the cumulative % drug release  
was calculated. 
8. Drug Release Kinetics 
To know the release kinetics, the data obtained from the in-vitro release profile was fitted into 
various models like : 
 Zero order kinetic model: cumulative percent drug release v/s time 
 First order kinetic model:  log cumulative percent drug remaining v/s time 
 Higuchi’s model: cumulative percent drug release v/s square root of time 
 Korsmeyer - Peppas model: log cumulative percent drug release v/s log time 
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Zero order kinetics: 
It describes the system in which the drug release rate is independent of its concentration. 
                                                      Qt = Q0 + K0t                                                              ………(4) 
Where, 
Qt = Amount of drug dissolved in time t 
Q0 = Initial amount of drug in the solution, which is often 0 
K0 =Zero order release constant 
If the release pattern obeys zero order, then the plot of  Qt v/s t will give a straight line with a 
slope of K0 and an intercept at 0. 
First order kinetics 
It describes the drug release from the systems in which the release rate is concentration 
dependent. 
                                                       log Qt = log Q0 + kt/2.303                                         ……….(5) 
Where,  
Qt = Amount of drug released in time t 
Q0 = Initial amount of drug in the solution 
K = First order release constant 
If the release pattern obeys first order, then the plot of log (Q0-Qt) v/s t will be straight line with a 
slope of kt/2.303 and an intercept at t = log Q0. 
Higuchi model 
According to this model, the fraction of drug from the system is proportional to the square root 
of time. 
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                                                                   Mt/Mα = kHt1/2                                                                      ………(6) 
Where,       Mt  & Mα = Cumulative amounts of drug release at time t and at infinity 
                    kH          = Higuchi dissolution constant (reflects formulation characteristics) 
If the Higuchi model of drug release is obeyed, then a plot of Mt/M ∞ v/s t ½ will be straight line 
with slope of kH.   
Korsmeyer – Peppas model (power law)  
The power law describes the drug release from the polymeric system in which the release 
deviates from Fickian diffusion. It is expressed using the following equations : 
Mt/Mα =ktn                                                                                                                        ………(7) 
log [Mt/Mα] = log k + n log t                                                                                           ………(8) 
Where,     Mt & Mα = Cumulative amounts of drug release at time t and at infinity 
                 k = Constant incorporating structural and geometrical characteristics of the system  
                n = Exponent determining the mechanism of drug release 
To characterize the release mechanism, the dissolution data (Mt/Mα < 0.6 ) are evaluated. 
A plot of Mt/Mα v/s log t will be linear with slope n and intercept value of log k. Antilog of k 
gives the value of k. Peppas used the n value in order to characterize different release 
mechanisms as shown below: 
                                                     Table 7: Release Mechanisms 
‘n’ value Drug Release 
<0.5 Fickian  
0.5<n<1 Non – Fickian 
>1 Case 2 transport 
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STABILITY STUDIES 
Stability of a drug in a dosage form at different environmental conditions is important, because it 
determines the expiry date of that formulation. Hence, the stability of the prepared formulation 
was studied. Stability studies were conducted according by storing the gel formulation at 40oC ± 
20C, 70% RH ±5% for 45 days. The samples were withdrawn at initial, 30th & 45th day and 
analyzed suitably for the physical characteristics, drug content and cumulative drug release. 
Results and discussion 
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                                RESULTS AND DISCUSSION 
Calibration Curve Of Morinda citrifolia Extract 
The λ
max
 of  Morinda citrifolia Extract was determined by scanning the prepared solution in the 
wavelength range of 200-400 nm. The maximum wavelength was found to be 279nm. The 
calibration curve of  Morinda citrifolia extract  was constructed by dissolving the drug in pH 7.4 
phosphate buffer. The linearity of the curve was found in the concentration range of 2-10µg/ml. 
A regression coefficient (R2) value of 0.9989 was obtained. 
                    Table 8: Calibration curve data of Morinda citrifolia extract 
 
 
 
 
 
 
 
                                        
        Figure No:8 Calibration curve of  Morinda citrifolia extract 
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EVALUATION OF PHYTOSOMAL COMPLEX 
1. Optical Microscopy 
Optical microscopy was performed by viewing the formulations under microscope. It was 
observed that the preparations showed vesicle formation. The vesicles formed were found to be 
of uniform size and shape. 
2. Percentage Practical Yield 
                                   Table No:9 Results of Percentage Practical Yield  
Formulation Percentage  PracticalYield 
F1 91.34 
F2 88.51 
F3 86.87 
F4 86.04 
F5 85.42 
F6 83.87 
F7 81.09 
 
% Practical Yield of different formulations was shown in table No:7. F1 have higher % Practical 
yield of 91.34% than other formulations.  
3. Entrapment Efficiency 
                                     Table No:10 Results of Entrapment Efficiency 
Formulation PercentageEntrapment Efficiency 
F1 89.87 
F2 86.94 
F3 84.71 
F4 79.09 
F5 75.08 
F6 71.58 
F7 67.47 
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The entrapment efficiency was calculated from the absorbance obtained from the supernatant 
solution. The formulation F1 showed highest release entrapment efficiency of 89.87% indicating 
the optimum amount of lipid required for the formation of  phytosomes. With further increase in 
the lipid concentration, the entrapment efficiency decreased indicating that the lipid 
concentration did not help in entrapping the drug into the matrix. 
           4. Drug Content 
                                                Table No: 11 Results of Drug Content 
Formulation Drug Content (%W/W) 
F1 88.43 
F2 86.84 
F3 86.22 
F4 84.19 
F5 83.49 
F6 80.76 
F7 78.08 
 
The drug content of Morinda citrifolia extract in the complexes was found to be in the range of 
88.43% - 78.08% indicating the presence of an acceptable amount of drug in the formulations. 
The percentage of drug loading decreased with an increase in the concentration of lipid. The 
formulation F1 showed the maximum drug content of 88.43%. 
5. Solubility Determination 
The solubility of the Morinda citrifolia phytosomes was found to be much higher than the pure 
drug extract. The increase in solubility of drug extract in the complex can be explained by the 
solubilization theory resulted from the formation of micelle in the medium and also by the 
amorphous nature of the complex. These amphiphilic surfactants (phospholipids) may increase 
the solubility of the drug extract by their wetting and dispersion properties. The formulation F1 
exhibited the highest degree of solubility.    
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                        Table No:12 Solubility profile in different media 
 
Formulation 
Solubility in 
Water 
(mg/ml)  
Solubility in 
pH7.4 Phosphate 
Buffer (mg/ml)  
Solubility in  
n-Octanol 
(mg/ml)  
Drug Extract 0.143 0.197 0.231 
F1 0.789 5.273 5.976 
F2 0.781 5.151 5.640 
F3 0.652 4.837 5.284 
F4 0.694 3.950 4.569 
F5 0.528 3.752 4.191 
F6 0.573 3.864 4.237 
F7 0.617 4.356 4.587 
 
6.  In-vitro Drug Diffusion Study of Phytosomes 
                            Table No:13 Results of In-vitro Drug Diffusion Study  
Time 
in hrs 
Pure 
drug 
extract 
F1 F2 F3 F4 F5 F6 F7 
0.25 2.51 4.6 3.61 3.22 2.85 3.26 3.95 3.07 
0.5 8.66 11.58 10.37 9.88 8.64 9.54 7.85 7.33 
1 12.33 21.29 20.07 18.96 15.37 16.73 14.26 13.42 
2 15.06 33.16 27.68 25.65 23.03 23.46 20.11 16.66 
3 20.49 40.64 38.42 36.19 29.31 31.51 26.33 25.13 
4 27.86 51.36 44.74 42.34 37.77 39.22 35.21 31.05 
5 31.15 58.61 50.32 49.25 42.08 45.58 40.29 39.11 
6 36.4 65.77 57.35 53.64 48.2 50.96 48.07 45.28 
7 39.22 75.31 66.32 62.31 57.54 55.18 52.14 51.11 
8 46.78 84.33 74.62 69.23 62.03 64.41 60.17 58.19 
9 50.22 89.17 82.79 77.01 68.56 72.33 65.23 61.13 
10 54.16 91.23 86.34 81.26 72.48 76.23 70.03 65.31 
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                        Figure No:9 In-vitro Drug Diffusion Profile 
The phytosomes of Morinda citrifolia showed better diffusion profile than the pure drug extract. 
Unlike the free drug extract (which showed a total of only 54.16% drug release at the end of the 
10 hour), all the formulations showed the percentage cumulative drug release in the range of 
65.31 – 91.23%. The formulation F1 with drug extract: soya lecithin ratio of 1:1 showed the 
maximum release of 91.23% at the 10th hour. The diffusion of drug particles from its dosage 
form is a complex operation influenced by a number of factors like the particle size, crystal habit, 
surface area, surface energies and wettability. Wetting and dispersion properties of phospholipids 
(an amphiphilic surfactant) increased the solubility of the drug and hence improved the diffusion 
profile of the complex.  
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7. Ex-vivo Skin  Permeation Study 
Optimized formulation F1 was further subjected to the following studies: 
                                Table No:14 Results of Ex-vivo Skin Permeation Study 
Time in hours Cumulative % permeation 
0.25 5.36 
0.5 13.08 
1 21.76 
2 27.43 
3 34.22 
4 40.24 
5 46.03 
6 51.07 
7 59.35 
8 66.1 
9 73.46 
10 83.51 
11 90.23 
12 92.57 
 
                     
                                         Figure No:10 Drug Permeation Profile of F1 
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The drug permeation of the formulation F1 through the abdominal skin of chicken was carried 
using Franz diffusion cell and the results are reported in table no:12. The permeation profile was 
plotted between% cumulative drug permeated v/s time. It was observed that the formulation 
showed an optimum release of 92.57% over a period of 12 hours. 
 8. Scanning Electron Microcopy (SEM) Analysis 
      
                           Figure No:11  SEM image of Morinda citrifolia Phytosome(F1) 
The surface morphology of the formulated phytosome (optimized formulation )were confirmed 
by scanning electron microscopy. The vesicles are spherical in shape and smooth in nature. 
            EVALUATION OF GELS OF PHYTOSOME COMPLEX 
            1. Homogeneity 
                        Table No:15 Results of Homogeneity of Different Gel Formulations 
Formulation Homogeneity 
F1 Good 
F2 Good 
F3 Good 
F4 Good 
F5 Good 
F6 Good 
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The visual inspection of all the prepared gel formulations were carried out and it was     
concluded that all the gel formulations showed good appearance and homogeneity. 
 2.  Measurement of pH 
                                Table No:16 Results of pH of different gel formulations 
Formulation pH 
F1 5.4 
F2 5.2 
F3 5.3 
F4 5.7 
F5 5.1 
F6 5.6 
 
The pH of the gel formulations was in the range of 5.4 to 5.7, which lies in the normal pH range 
of the skin and would not produce any skin irritation. 
3. Drug Content 
                      Table No:17 Results of Drug Content of different Gel Formulation 
Formulation Drug Content(%) 
F1 90.29 
F2 89.17 
F3 87.79 
F4 87.42 
F5 85.21 
F6 82.37 
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The drug content of the formulated gels was estimated spectrophotometrically at 279nm. The 
drug content of all the formulation was found to be in the range of 82.37 % to 90.29% in which 
the best formulation F1 contained 90.29% of the drug. 
4. Rheological study 
                          Table No:18 Results of Viscosity of Different Gel Formulations 
Formulation Viscosity(Centipoise) 
F1 9564 
F2 10672 
F3 11296 
F4 12420 
F5 12717 
F6 13619 
 
The gel was rotated at 50 rpm for 10 minutes with spindle 64. The corresponding reading was 
noted. The viscosity of the formulations increases as concentration of polymer increases. The 
viscosity of the best formulation was found to be 9564 centipoise. 
5. Spreadability  
                      Table No:19 Results of Spredability of Different Gel Formulations 
Formulation Spreadability(cm) 
F1 4.1 
F2 3.8 
F3 3.3 
F4 3.6 
F5 3.5 
F6 2.9 
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Spreadability denotes the extent of area to which the gel readily spreads on application to skin or 
the affected part. The spreadability of the prepared gel formulations was carried out and it was 
concluded that all the formulation showed acceptable spreadability. The spreadability coefficient 
of the best formulation F1 was found to be 4.1cm. The value of spreadability indicates the gel 
was easily spreadable by small amount of shear. 
6. Extrudability 
                      Table No:20 Results of Extrudability of Different Gel Formulations 
Formulation Extrudability(gm/cm2) 
F1 9.3 
F2 11.2 
F3 13.1 
F4 13.7 
F5 14.3 
F6 14.7 
 
It was found that extrudability of the prepared gel formulation was a function of concentration of 
gelling agents. Extrudability was decreased with increase in concentration of gelling agents. The 
extrudability of the best formulation F1 was found to be 9.3 gm/cm2. Thus the prepared gel 
posses optimum extrudability. 
7. In-vitro drug release study 
The in-vitro permeation studies of all the formulations were carried out using Franz diffusion cell 
wtih egg membrane as a diffusion membrane for the study as described in the methodology 
section. 
The comparative data of cumulative % drug permeation of the formulations were shown in table 
no: 20 and the figure no: 11. Cumulative % drug release of the prepared gel formulations after12 
hours was found to be in the range of 66.32% to 89.95%. The drug release from F1 was found to 
be higher due to the lower concentration of the gelling agent and F6  showed lower drug release 
due to the higher concentration of the gelling agent. 
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        Table No: 21 Results of In-vitro drug release study of Gel Formulations 
Time 
in 
hours 
F1 F2 F3 F4 F5 F6 
0.5 10.36 9.11 8.47 7.23 5.92 5.92 
1.5 12.63 11.06 10.34 9.24 8.03 7.34 
1 18.07 15.07 13.36 11.65 10.56 9.18 
2 24.1 20.15 17.54 14.87 13.76 10.94 
3 30.17 24.65 20.54 18.65 17.45 14.23 
4 35.17 27.67 22.45 20.87 20.12 17.65 
5 38.14 30.65 27.34 26.56 25.43 23.01 
6 43.58 35.65 33.44 30.67 29.54 26.25 
7 52.07 39.78 36.55 35.42 34.76 31.11 
8 59.34 48.19 44.13 40.63 38.95 35.78 
9 67.46 58.74 52.85 48.63 45.65 40.67 
10 74.02 66.13 59.65 57.57 53.23 49.63 
11 84.27 74.16 68.13 65.13 61.76 60.54 
12 89.35 80.56 73.48 69.03 68.49 66.32 
 
                          
 
             Figure No:12 In-vitro Drug Diffusion Profile of Gel Formulation 
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8. Drug Release Kinetics 
Based on the data obtained from the in-vitro drug release studies the best formulation F1 was 
analyzed for the release kinetic studies. The cumulative release of drug was fitted into various 
plots like Zero order, First order and Higuchi model to know the pattern of release and 
Korsmeyer-Peppas model in order to find out the mechanism of release from the prepared 
pharmacosome. The model that best fits the release data is selected based on the regression 
coefficient value of various models. 
                      
                                               Figure No:13 Zero Order Plot 
 
          
                                              Figure No:14 First Order Plot 
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                                                     Figure No:15 Higuchi Plot 
 
               
                                                      Figure No: 16 Korsmeyer-Peppas Plot 
 
                                            Table No:22 Results of kinetic analysis 
 
Formulation 
Zero 
order 
First 
order 
Higuchi 
model 
Korsmeyer- 
Peppas model 
R2 R2 R2 n R2 
F1 0.932 0.848 0.981 0.696 0.961 
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From the regression coefficient values obtained, it was found out that the formulation follows the 
Higuchi model kinetics. The slope value (n) obtained from Peppas plot was 0.696, which 
indicates that the formulation followed Non-Fickian diffusion mechanism of drug release. 
          9. Stability Studies 
                                  Table No:23 Stability Studies For F1 Formulation 
              
 
 
 
 
 
   
 
The purpose of the stability testing is to provide evidence on how the quality of a drug substance 
or drug varies with time under the influence of variety of environmental factors like temperature, 
humidity and light and to establish a test period for the drug substance or a shelf life for the drug 
and recommended storage conditions. Here the gel are packed in collapsible aluminum tubes and 
were loaded at accelerated condition at 40 ± 2°C/ RH 70 ± 5% RH in a stability chamber. 
Samples were withdrawn at initial 40 ± 2°C/ RH 70 ± 5% and days and evaluated for 
homogeneity, drug content, pH, spreadability, extrudability, viscosity and in-vitro diffusion 
profile. The results showed that the storage at these conditions had no effect on those parameters.
 
 
 
Sl.No Parameters Initial 30
th
 
Day 
45
th
 
Day 
1 Homogeneity Good Good Good 
2 Drug Content(%) 90.29 90.23 90.23 
3 pH 5.4 5.4 5.4 
4 Spreadability(cm) 4.1 4.1 4 
5 Extrudability(gm/cm
2
) 9.3 9.3 9.3 
6 Viscosity (cps) 9564 9561 9555 
7 % cumulative release 89.35 89.30 88.83 
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SUMMARY  
Morinda citrifolia L. (Noni) have been used for thousands of years for the treatment of many 
health problems including cancer, cold, diabetes, flu, hypertension and pain. Scientific 
investigations reported its antioxidant, antifungal , anti bacterial, anti-inflammatory, liver 
protective, anticancer, analgesic, immunomodulatory, anti viral and wound healing activities. 
Even though extracts have reported several therapeutic benefits, but extraction of individual 
compound from it often exhibits limited clinical utility as the synergistic effect of various natural 
ingredients gets lost and the various phytoconstituents present in it  are poorly absorbed either 
due to their large molecular size, which cannot be absorbed by passive diffusion or due to their 
poor lipid solubility, thus severely limiting their ability to transport across lipid-rich biological 
membranes, resulting in their poor bioavailability. 
 
 Phytosome technology has proved to be beneficial in providing better absorption and 
bioavailability of polar biomolecules over conventional herbal extracts. Hence the present study 
was aimed to prepare and evaluate topical phytosomal gel of Morinda citrifolia with an objective 
to increase its bioavailability and therapeutic efficacy.   
 
Formulation 
 Morinda citrifolia phytosomes was prepared by the anti solvent precipitation technique using 
different ratios of drug and soya lecithin. A total of 7 formulations were prepared. From the 
prepared formulation the best formulation which contained drug extract: soya lecithin in the 
ratio 1:1 was selected based on various evaluation parameters and was incorporated into a gel 
base of different concentration using carbopol 934 as a polymer. 
UV spectrophotometric method was developed for determining λmax of Morinda citrifolia 
extract 
Evaluation 
 The phytosomal formulations were subjected to various studies like percentage yield , 
solubility, drug content , entrapment efficiency, in vitro drug release studies.  
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 The optimized formulation was further subjected to ex-vivo skin permeation study and 
SEM analysis. 
 The prepared gel formulations was evaluated  for pH,  spreadability coefficient, 
extrudability, drug content,  rheological studies and in-vitro drug diffusion study. 
 Release kinetic data revealed that the gel followed Higuchi model kinetics with non-
Fickian diffusion of drug. 
 Stability studies were carried out at accelerated temperature 40oC ± 20C, 70% RH ±5% 
for 45 days. There were no significant changes in the homogeneity, drug content, pH, 
spreadability, extrudability, viscosity and in-vitro diffusion profile. 
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CONCLUSION 
The novel drug delivery system research area of herbal drugs is an innovative work that target 
for phytoconstituents and plant extracts regarding the therapeutic and cosmetic usefulness of 
plant products particularly containing flavonoids and poly phenolic compounds. However,due to 
its poor lipid solubility and larger molecular size limiting their ability to pass across the lipid-rich 
biological membranes, resulting poor bioavailability. Different reports show a promising future 
of phytosome as an advanced form of herbal products that are better absorbed, utilized, and as a 
result produce better results than conventional herbal extracts. The complexation of 
phytoconstituents and phospholipids makes the phytoconstituents more stable in the complex 
form due to liopophilic nature and offering the herbal drugs with sufficient lipid penetrability, 
higher concentration, sustained therapeutic levels and increased cosmetic value. It was confirmed 
that Morinda citrifolia phytosoml gel showed a better diffusion as well as stability profile, hence 
providing an attractive carrier for the delivery of various phytoconstituents present in it. In 
conclusion, the application of phytosomal formulation as topical pharmaceutical agent and 
cosmetics with improved safety and efficacy results in proper utilization of herbal drugs and cost 
effective pharmaceutical product. 
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ABSTRACT 
The emerging technology of drug delivery is being applied to phyto‐pharmaceuticals to 
improve the bioavailability of herbal extracts for medicinal applications. Phytosome is a 
novel emerging technique applied to phyto-pharmaceutical which contains 
phytoconstituents of herbal extract surrounds and bound by lipid. Several plant extracts 
and phyto constituents are having excellent bioactivity in vitro, demonstrate less or no in-
vivo actions  due to their poor lipid solubility or larger molecular size or both, resulting 
poor absorption and bioavailability. So, much work has been directed towards the 
development of new concept in herbal delivery system i.e., phytosomes which are better 
absorbed, utilized and as a result produce better results than conventional herbal 
extracts.The design of the present investigation was to prepare and develop phytosomal 
complex of Morinda citrifolia with different ratio of drug extract and soyalecithin. A total 
of 7 formulations were prepared by anti solvent precipitation method and evaluated for 
percentage yield, solubility, drug content, entrapment efficiency, in vitro drug release 
studies and ex-vivo drug permeation studies. The optimized formulation of phytosome 
was incorporated into a gel base of different concentration and was subjected to various 
evaluation studies. The in-vitro diffusion and kinetic study of the gel showed a release of 
89.35% over 12 hours and fitted into Higuchi Model Kinetics and non-Fickian diffusion 
mechanism. The formulation was found to be stable at an accelerated temperature of 40° 
± 2°C, RH 70 %± 5 % for 45 days. It could be concluded that the formulation F1 having 
drug extract: soyalecithin 1:1 was the best formulation. The SEM image of the optimized 
formulation was taken. 
 
Keywords: Phytosome, Phytoconstituents, Bioavailability In vitro drug release, 
Ex-vivo drug permeation study, SEM 
